{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Analysis of clinical trials for hepatocellular carcinoma"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import requests\n",
    "import json\n",
    "import numpy as np\n",
    "from bs4 import BeautifulSoup\n",
    "import lxml\n",
    "import pandas as pd\n",
    "import xml.etree.ElementTree as et\n",
    "from os import listdir\n",
    "from os.path import isfile, join"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## NCI API interaction"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# NCI clinical trials\n",
    "params={'name': 'hepatocellular carcinoma'}\n",
    "response = requests.get('https://clinicaltrialsapi.cancer.gov/v1/diseases', params=params)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "200"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response.status_code"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'{\"terms\":[{\"name\":\"Hepatitis B Virus-Related Hepatocellular Carcinoma\",\"codes\":[\"C27687\"],\"ancestor_ids\":[\"C3099\",\"C7927\"],\"parent_ids\":[\"C3099\"],\"type\":[\"subtype\"]},{\"name\":\"Hepatitis C Virus-Related Hepatocellular Carcinoma\",\"codes\":[\"C27688\"],\"ancestor_ids\":[\"C3099\",\"C7927\"],\"parent_ids\":[\"C3099\"],\"type\":[\"subtype\"]}]}'"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Convert content from byte object to string\n",
    "response.content.decode(\"utf-8\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'str'>\n",
      "{'terms': [{'name': 'Hepatitis B Virus-Related Hepatocellular Carcinoma', 'codes': ['C27687'], 'ancestor_ids': ['C3099', 'C7927'], 'parent_ids': ['C3099'], 'type': ['subtype']}, {'name': 'Hepatitis C Virus-Related Hepatocellular Carcinoma', 'codes': ['C27688'], 'ancestor_ids': ['C3099', 'C7927'], 'parent_ids': ['C3099'], 'type': ['subtype']}]}\n",
      "{'terms': [{'name': 'Hepatitis B Virus-Related Hepatocellular Carcinoma', 'codes': ['C27687'], 'ancestor_ids': ['C3099', 'C7927'], 'parent_ids': ['C3099'], 'type': ['subtype']}, {'name': 'Hepatitis C Virus-Related Hepatocellular Carcinoma', 'codes': ['C27688'], 'ancestor_ids': ['C3099', 'C7927'], 'parent_ids': ['C3099'], 'type': ['subtype']}]}\n",
      "<class 'dict'>\n"
     ]
    }
   ],
   "source": [
    "# Use JSON to convert python object to str\n",
    "print(type(json.dumps(response.content.decode(\"utf-8\"))))\n",
    "print(json.loads(response.content.decode(\"utf-8\")))\n",
    "\n",
    "# Use JSON to convert str to python object\n",
    "print(json.loads(response.content))\n",
    "print(type(json.loads(response.content)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'terms': [{'ancestor_ids': ['C3099', 'C7927'],\n",
       "   'codes': ['C27687'],\n",
       "   'name': 'Hepatitis B Virus-Related Hepatocellular Carcinoma',\n",
       "   'parent_ids': ['C3099'],\n",
       "   'type': ['subtype']},\n",
       "  {'ancestor_ids': ['C3099', 'C7927'],\n",
       "   'codes': ['C27688'],\n",
       "   'name': 'Hepatitis C Virus-Related Hepatocellular Carcinoma',\n",
       "   'parent_ids': ['C3099'],\n",
       "   'type': ['subtype']}]}"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Convert response to dictionary\n",
    "data = response.json()\n",
    "data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## XML clinical trial data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Use Clinicaltrials.gov API to download trial information in XML format\n",
    "# https://clinicaltrials.gov/ct2/results/download_fields?cond=hepatocellular+carcinoma&down_count=1000&down_fmt=xml"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Use BeautifulSoup to parse XML files\n",
    "with open(\"data/ctgov_hcc_results/NCT01411579.xml\") as fp:\n",
    "    soup = BeautifulSoup(fp, \"xml\")\n",
    "soup.phase == True"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Webscrape XML data\n",
    "\n",
    "with open(\"data/ctgov_hcc_results/NCT00003147.xml\") as fp:\n",
    "    soup = BeautifulSoup(fp, \"xml\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "phase = soup.phase.contents[0]\n",
    "overall_status = soup.overall_status.contents[0],"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Use ElementTree\n",
    "tree = et.parse('data/ctgov_hcc_results/NCT00003147.xml')\n",
    "root = tree.getroot()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Extract facility information from XML. Add to dictionary of facilities with address information\n",
    "\n",
    "trial_file = 'data/ctgov_hcc_results/NCT00003147.xml'\n",
    "\n",
    "def get_facilities(trial_file):\n",
    "    \n",
    "    tree = et.parse(trial_file)\n",
    "    root = tree.getroot()\n",
    "\n",
    "    facility_dict = {}\n",
    "    \n",
    "    for i, facility in enumerate(root.findall('./location/facility')):\n",
    "        \n",
    "        address_tree = facility.find('address')\n",
    "        \n",
    "        # add elements to dictionary\n",
    "        address_dict = {}\n",
    "        \n",
    "        if address_tree.find('city') != None:\n",
    "            city = address_tree.find('city').text\n",
    "            address_dict['city'] = city\n",
    "        if address_tree.find('state') != None:\n",
    "            state = address_tree.find('state').text\n",
    "            address_dict['state'] = state\n",
    "        if address_tree.find('zip') != None:\n",
    "            zipcode = address_tree.find('zip').text\n",
    "            address_dict['zip'] = zipcode\n",
    "        if address_tree.find('country') != None:\n",
    "            country = address_tree.find('country').text\n",
    "            address_dict['country'] = country\n",
    "        \n",
    "        if facility.find('name') != None:\n",
    "            name = facility.find('name').text\n",
    "            facility_dict[name] = address_dict # add to facility dictionary\n",
    "        else:\n",
    "            facility_dict['unnamedFacility_' + str(i)] = address_dict # add to facility dictionary\n",
    "    \n",
    "    return facility_dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'Johns Hopkins Oncology Center': {'city': 'Baltimore', 'state': 'Maryland', 'zip': '21287', 'country': 'United States'}, 'Mayo Clinic Cancer Center': {'city': 'Rochester', 'state': 'Minnesota', 'zip': '55905', 'country': 'United States'}, 'Prince of Wales Hospital': {'city': 'Shatin, New Territories', 'country': 'Hong Kong'}}\n"
     ]
    }
   ],
   "source": [
    "trial_file = 'data/ctgov_hcc_results/NCT00003044.xml'\n",
    "print(get_facilities(trial_file))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'Albert Einstein Comprehensive Cancer Center': {'city': 'Bronx', 'state': 'New York', 'zip': '10461', 'country': 'United States'}, 'University of Pittsburgh Cancer Institute': {'city': 'Pittsburgh', 'state': 'Pennsylvania', 'zip': '15213', 'country': 'United States'}}\n"
     ]
    }
   ],
   "source": [
    "trial_file = 'data/ctgov_hcc_results/NCT00003147.xml'\n",
    "print(get_facilities(trial_file))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Extract relevant trial information from XML file and input into dictionary\n",
    "\n",
    "trial_file = 'data/ctgov_hcc_results/NCT00003147.xml'\n",
    "\n",
    "def extract_trial_info(trial_file):\n",
    "    \n",
    "    with open(trial_file) as fp:\n",
    "        soup = BeautifulSoup(fp, \"xml\")\n",
    "    \n",
    "    trial_dict = {}\n",
    "    \n",
    "    trial_name = soup.nct_id.contents[0]\n",
    "    if soup.nct_id != None:\n",
    "        trial_dict['nct_id'] = soup.nct_id.contents[0]\n",
    "    if soup.brief_title != None:\n",
    "        trial_dict['brief_title'] = soup.brief_title.contents[0]\n",
    "    if soup.official_title != None:\n",
    "        trial_dict['official_title'] = soup.official_title.contents[0]\n",
    "    if soup.phase == True:\n",
    "        trial_dict['phase'] = soup.phase.contents[0]\n",
    "    if soup.overall_status != None:\n",
    "        trial_dict['status']= soup.overall_status.contents[0]\n",
    "    if soup.detailed_description != None:\n",
    "        trial_dict['description']= soup.detailed_description.textblock.contents[0]\n",
    "    if soup.eligibility:\n",
    "        if soup.eligibility.criteria != None:\n",
    "            trial_dict['criteria']= soup.eligibility.criteria.textblock.contents[0]\n",
    "        if soup.eligibility.gender:\n",
    "            trial_dict['gender']= soup.eligibility.gender.contents[0]\n",
    "        if soup.eligibility.minimum_age != None:\n",
    "            trial_dict['min_age']= soup.eligibility.minimum_age.contents[0]\n",
    "        if soup.eligibility.maximum_age != None:\n",
    "            trial_dict['max_age']= soup.eligibility.maximum_age.contents[0]\n",
    "    if soup.study_type != None:\n",
    "        trial_dict['study_type']= soup.study_type.contents[0]\n",
    "    if soup.brief_summary != None:\n",
    "        trial_dict['summary']= soup.brief_summary.textblock.contents[0]\n",
    "    trial_dict['facilities'] = get_facilities(trial_file)\n",
    "    \n",
    "    return trial_name, trial_dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NCT00003147 {'nct_id': 'NCT00003147', 'brief_title': 'Gene Therapy in Treating Patients With Cancer of The Liver', 'official_title': 'Phase I Study of Percutaneous Injections of Adeno-Virus p53 Construct (ADENO-p53) for Hepatocellular Carcinoma', 'status': 'Terminated', 'description': '\\n      OBJECTIVES:\\n\\n      I. Determine the safety of adenovirus p53 construct (adeno-p53) in patients with\\n      hepatocellular carcinoma.\\n\\n      II. Investigate the potential effects of intralesional adeno-p53 given by monthly\\n      percutaneous injections in these patients.\\n\\n      OUTLINE: This is a dose escalation, multicenter study.\\n\\n      Patients receive adenovirus p53 construct by percutaneous injection to a maximum of two\\n      lesions on day 1. Treatment is repeated every 28 days for up to 6 courses. In the absence of\\n      dose-limiting toxicity (DLT) in the first cohort of 6 patients treated, subsequent cohorts of\\n      6 patients each receive escalating doses of the drug on the same schedule. If DLT occurs in 2\\n      of 6 patients at a given dose level, then dose escalation ceases and that dose is declared\\n      the maximum tolerated dose. Study treatment may continue in the absence of disease\\n      progression and unacceptable adverse events.\\n    ', 'criteria': \"\\n        DISEASE CHARACTERISTICS:\\n\\n          -  Histologically confirmed unresectable hepatocellular carcinoma (HCC) or highly\\n             suspicious for HCC based on CT scan and elevated alfafetoprotein\\n\\n          -  Measurable disease by abdominal CT scan Accessible (peripheral) lesions\\n\\n          -  No metastatic disease\\n\\n        PATIENT CHARACTERISTICS:\\n\\n          -  Age: Over 18\\n\\n          -  Performance status: ECOG 0-2\\n\\n          -  Life expectancy: At least 12 weeks\\n\\n          -  Platelet count at least 60,000/mm3\\n\\n          -  Absolute neutrophil count greater than 1,500/mm3\\n\\n          -  Prothrombin time of no greater than 16 seconds after administration of fresh frozen\\n             plasma\\n\\n          -  Bilirubin no greater than 3.0 mg/dL\\n\\n          -  Creatinine less than 1.5 mg/dL\\n\\n          -  Child's class A or B cirrhosis eligible\\n\\n          -  No uncontrolled infection Not pregnant or breast feeding\\n\\n          -  No unstable or severe intercurrent medical condition\\n\\n        PRIOR CONCURRENT THERAPY:\\n\\n          -  At least 4 weeks since prior chemotherapy\\n\\n          -  At least 4 weeks since prior radiation therapy\\n\\n          -  No prior hepatic transplantation\\n\\n          -  No more than 1 prior systemic regimen for hepatocellular carcinoma allowed\\n\\n          -  No concurrent therapy with other investigational agents\\n\\n          -  No prior gene therapy\\n\\n          -  No prior intralesional therapy\\n      \", 'gender': 'All', 'min_age': '18 Years', 'max_age': 'N/A', 'study_type': 'Interventional', 'summary': \"\\n      Phase I trial to study the effectiveness of gene therapy with the p53 gene in treating\\n      patients who have cancer of the liver that cannot be surgically removed. Inserting the p53\\n      gene into a person's tumor may improve the body's ability to fight liver cancer.\\n    \", 'facilities': {'Albert Einstein Comprehensive Cancer Center': {'city': 'Bronx', 'state': 'New York', 'zip': '10461', 'country': 'United States'}, 'University of Pittsburgh Cancer Institute': {'city': 'Pittsburgh', 'state': 'Pennsylvania', 'zip': '15213', 'country': 'United States'}}}\n"
     ]
    }
   ],
   "source": [
    "trial_file = 'data/ctgov_hcc_results/NCT00003147.xml'\n",
    "\n",
    "trial_name, trial_dict = extract_trial_info(trial_file)\n",
    "print(trial_name, trial_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>brief_title</th>\n",
       "      <th>criteria</th>\n",
       "      <th>description</th>\n",
       "      <th>facilities</th>\n",
       "      <th>gender</th>\n",
       "      <th>max_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>status</th>\n",
       "      <th>study_type</th>\n",
       "      <th>summary</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Gene Therapy in Treating Patients With Cancer ...</td>\n",
       "      <td>DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...</td>\n",
       "      <td>OBJECTIVES:\n",
       "\n",
       "      I. Determine the saf...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NCT00003147</td>\n",
       "      <td>Phase I Study of Percutaneous Injections of Ad...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase I trial to study the effectivenes...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         brief_title  \\\n",
       "0  Gene Therapy in Treating Patients With Cancer ...   \n",
       "\n",
       "                                            criteria  \\\n",
       "0  \n",
       "        DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...   \n",
       "\n",
       "                                         description  facilities gender  \\\n",
       "0  \n",
       "      OBJECTIVES:\n",
       "\n",
       "      I. Determine the saf...         NaN    All   \n",
       "\n",
       "  max_age   min_age       nct_id  \\\n",
       "0     N/A  18 Years  NCT00003147   \n",
       "\n",
       "                                      official_title      status  \\\n",
       "0  Phase I Study of Percutaneous Injections of Ad...  Terminated   \n",
       "\n",
       "       study_type                                            summary  \n",
       "0  Interventional  \n",
       "      Phase I trial to study the effectivenes...  "
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.DataFrame(trial_dict, index=[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Extract clinical trial data from multiple XML files in folder\n",
    "\n",
    "def collect_trial_data(path, num_files=100):\n",
    "\n",
    "    files = listdir(path=path)\n",
    "    trials = {}\n",
    "    \n",
    "    i = 0\n",
    "    for file in files:\n",
    "        if i <= num_files:\n",
    "        \n",
    "            trial_file = path + file\n",
    "            trial_name, trial_dict = extract_trial_info(trial_file)\n",
    "            trials[trial_name] = trial_dict \n",
    "        i += 1\n",
    "    \n",
    "    return trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_folder = 'data/ctgov_hcc_results/'\n",
    "\n",
    "trials = collect_trial_data(path_folder, num_files=100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>brief_title</th>\n",
       "      <th>criteria</th>\n",
       "      <th>description</th>\n",
       "      <th>facilities</th>\n",
       "      <th>gender</th>\n",
       "      <th>max_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>status</th>\n",
       "      <th>study_type</th>\n",
       "      <th>summary</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>NCT00004108</th>\n",
       "      <td>DX-8951f in Treating Patients With Liver Cancer</td>\n",
       "      <td>DISEASE CHARACTERISTICS: Histological...</td>\n",
       "      <td>OBJECTIVES: I. Evaluate the antitumor a...</td>\n",
       "      <td>{'University of Colorado Cancer Center': {'cit...</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>16 Years</td>\n",
       "      <td>NCT00004108</td>\n",
       "      <td>A Phase II Study of Intravenous DX-8951f Admin...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>RATIONALE: Drugs used in chemotherapy u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00005997</th>\n",
       "      <td>Rebeccamycin Analogue in Treating Patients Wit...</td>\n",
       "      <td>DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...</td>\n",
       "      <td>OBJECTIVES:\n",
       "\n",
       "        -  Determine the r...</td>\n",
       "      <td>{'Comprehensive Cancer Center at University of...</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NCT00005997</td>\n",
       "      <td>Phase II and Pharmacokinetic Trial of Rebeccam...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>RATIONALE: Drugs used in chemotherapy u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00006332</th>\n",
       "      <td>Treatment of Hepatocellular Carcinoma With Tet...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Pat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'3912 Taubman Center': {'city': 'Ann Arbor', ...</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NCT00006332</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is a dea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00047346</th>\n",
       "      <td>Erlotinib in Treating Patients With Unresectab...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  His...</td>\n",
       "      <td>PRIMARY OBJECTIVES:\n",
       "\n",
       "      I. Establish...</td>\n",
       "      <td>{'M D Anderson Cancer Center': {'city': 'Houst...</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NCT00047346</td>\n",
       "      <td>A Dose-Finding, Safety, And Pharmacokinetic St...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase I trial to study the effectivenes...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00057395</th>\n",
       "      <td>A Safety and Effectiveness Study of Aroplatin ...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Adv...</td>\n",
       "      <td>Primary Objective:\n",
       "\n",
       "        -  Determin...</td>\n",
       "      <td>{'John Wayne Cancer Institute': {'city': 'Sant...</td>\n",
       "      <td>All</td>\n",
       "      <td>N/A</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NCT00057395</td>\n",
       "      <td>A Phase I/II Study of Aroplatin™ in Patients W...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>To determine the rate of response and t...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                   brief_title  \\\n",
       "NCT00004108    DX-8951f in Treating Patients With Liver Cancer   \n",
       "NCT00005997  Rebeccamycin Analogue in Treating Patients Wit...   \n",
       "NCT00006332  Treatment of Hepatocellular Carcinoma With Tet...   \n",
       "NCT00047346  Erlotinib in Treating Patients With Unresectab...   \n",
       "NCT00057395  A Safety and Effectiveness Study of Aroplatin ...   \n",
       "\n",
       "                                                      criteria  \\\n",
       "NCT00004108  \n",
       "        DISEASE CHARACTERISTICS: Histological...   \n",
       "NCT00005997  \n",
       "        DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...   \n",
       "NCT00006332  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Pat...   \n",
       "NCT00047346  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  His...   \n",
       "NCT00057395  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Adv...   \n",
       "\n",
       "                                                   description  \\\n",
       "NCT00004108  \n",
       "      OBJECTIVES: I. Evaluate the antitumor a...   \n",
       "NCT00005997  \n",
       "      OBJECTIVES:\n",
       "\n",
       "        -  Determine the r...   \n",
       "NCT00006332                                                NaN   \n",
       "NCT00047346  \n",
       "      PRIMARY OBJECTIVES:\n",
       "\n",
       "      I. Establish...   \n",
       "NCT00057395  \n",
       "      Primary Objective:\n",
       "\n",
       "        -  Determin...   \n",
       "\n",
       "                                                    facilities gender max_age  \\\n",
       "NCT00004108  {'University of Colorado Cancer Center': {'cit...    All     N/A   \n",
       "NCT00005997  {'Comprehensive Cancer Center at University of...    All     N/A   \n",
       "NCT00006332  {'3912 Taubman Center': {'city': 'Ann Arbor', ...    All     N/A   \n",
       "NCT00047346  {'M D Anderson Cancer Center': {'city': 'Houst...    All     N/A   \n",
       "NCT00057395  {'John Wayne Cancer Institute': {'city': 'Sant...    All     N/A   \n",
       "\n",
       "              min_age       nct_id  \\\n",
       "NCT00004108  16 Years  NCT00004108   \n",
       "NCT00005997  18 Years  NCT00005997   \n",
       "NCT00006332  18 Years  NCT00006332   \n",
       "NCT00047346  18 Years  NCT00047346   \n",
       "NCT00057395  18 Years  NCT00057395   \n",
       "\n",
       "                                                official_title  \\\n",
       "NCT00004108  A Phase II Study of Intravenous DX-8951f Admin...   \n",
       "NCT00005997  Phase II and Pharmacokinetic Trial of Rebeccam...   \n",
       "NCT00006332                                                NaN   \n",
       "NCT00047346  A Dose-Finding, Safety, And Pharmacokinetic St...   \n",
       "NCT00057395  A Phase I/II Study of Aroplatin™ in Patients W...   \n",
       "\n",
       "                     status      study_type  \\\n",
       "NCT00004108       Completed  Interventional   \n",
       "NCT00005997      Terminated  Interventional   \n",
       "NCT00006332       Completed  Interventional   \n",
       "NCT00047346       Completed  Interventional   \n",
       "NCT00057395  Unknown status  Interventional   \n",
       "\n",
       "                                                       summary  \n",
       "NCT00004108  \n",
       "      RATIONALE: Drugs used in chemotherapy u...  \n",
       "NCT00005997  \n",
       "      RATIONALE: Drugs used in chemotherapy u...  \n",
       "NCT00006332  \n",
       "      Hepatocellular carcinoma (HCC) is a dea...  \n",
       "NCT00047346  \n",
       "      Phase I trial to study the effectivenes...  \n",
       "NCT00057395  \n",
       "      To determine the rate of response and t...  "
      ]
     },
     "execution_count": 90,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "trials_df = pd.DataFrame(trials).transpose()\n",
    "trials_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "metadata": {},
   "outputs": [],
   "source": [
    "# clean dataframe\n",
    "trials_df['min_age'] = trials_df['min_age'].str.replace('Years', '')\n",
    "trials_df['min_age'] = trials_df['min_age'].str.replace(' ', '')\n",
    "trials_df['min_age'].loc[trials_df['min_age'] == 'N/A'] = 0\n",
    "trials_df['min_age'] = trials_df['min_age'].apply(int)\n",
    "\n",
    "trials_df['max_age'] = trials_df['max_age'].str.replace('Years', '')\n",
    "trials_df['max_age'] = trials_df['max_age'].str.replace(' ', '')\n",
    "trials_df.loc[trials_df['max_age'] == 'N/A', 'max_age'] = 100\n",
    "trials_df.loc[trials_df['max_age'] == '10Days', 'max_age'] = 1\n",
    "trials_df['max_age'] = trials_df['max_age'].apply(int)\n",
    "\n",
    "trials_df['brief_title'] = trials_df['brief_title'].apply(str)\n",
    "trials_df['official_title'] = trials_df['official_title'].apply(str)\n",
    "trials_df['description'] = trials_df['description'].apply(str)\n",
    "trials_df['summary'] = trials_df['summary'].apply(str)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Interventional                      84\n",
       "Observational                       13\n",
       "Expanded Access                      3\n",
       "Observational [Patient Registry]     1\n",
       "Name: study_type, dtype: int64"
      ]
     },
     "execution_count": 92,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "trials_df['study_type'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>brief_title</th>\n",
       "      <th>criteria</th>\n",
       "      <th>description</th>\n",
       "      <th>facilities</th>\n",
       "      <th>gender</th>\n",
       "      <th>max_age</th>\n",
       "      <th>min_age</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>official_title</th>\n",
       "      <th>status</th>\n",
       "      <th>study_type</th>\n",
       "      <th>summary</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>NCT00004108</th>\n",
       "      <td>DX-8951f in Treating Patients With Liver Cancer</td>\n",
       "      <td>DISEASE CHARACTERISTICS: Histological...</td>\n",
       "      <td>OBJECTIVES: I. Evaluate the antitumor a...</td>\n",
       "      <td>{'University of Colorado Cancer Center': {'cit...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>16</td>\n",
       "      <td>NCT00004108</td>\n",
       "      <td>A Phase II Study of Intravenous DX-8951f Admin...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>RATIONALE: Drugs used in chemotherapy u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00005997</th>\n",
       "      <td>Rebeccamycin Analogue in Treating Patients Wit...</td>\n",
       "      <td>DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...</td>\n",
       "      <td>OBJECTIVES:\n",
       "\n",
       "        -  Determine the r...</td>\n",
       "      <td>{'Comprehensive Cancer Center at University of...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00005997</td>\n",
       "      <td>Phase II and Pharmacokinetic Trial of Rebeccam...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>RATIONALE: Drugs used in chemotherapy u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00006332</th>\n",
       "      <td>Treatment of Hepatocellular Carcinoma With Tet...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Pat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'3912 Taubman Center': {'city': 'Ann Arbor', ...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00006332</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is a dea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00047346</th>\n",
       "      <td>Erlotinib in Treating Patients With Unresectab...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  His...</td>\n",
       "      <td>PRIMARY OBJECTIVES:\n",
       "\n",
       "      I. Establish...</td>\n",
       "      <td>{'M D Anderson Cancer Center': {'city': 'Houst...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00047346</td>\n",
       "      <td>A Dose-Finding, Safety, And Pharmacokinetic St...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase I trial to study the effectivenes...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00057395</th>\n",
       "      <td>A Safety and Effectiveness Study of Aroplatin ...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Adv...</td>\n",
       "      <td>Primary Objective:\n",
       "\n",
       "        -  Determin...</td>\n",
       "      <td>{'John Wayne Cancer Institute': {'city': 'Sant...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00057395</td>\n",
       "      <td>A Phase I/II Study of Aroplatin™ in Patients W...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>To determine the rate of response and t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00077441</th>\n",
       "      <td>Bortezomib in Treating Patients With Hepatocel...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  His...</td>\n",
       "      <td>PRIMARY OBJECTIVES:\n",
       "\n",
       "      I. Proportio...</td>\n",
       "      <td>{'Mayo Clinic': {'city': 'Rochester', 'state':...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00077441</td>\n",
       "      <td>Phase II Trial of PS-341 in Patients With Hepa...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This phase II trial is studying how wel...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00109954</th>\n",
       "      <td>Hepatic Arterial Chemoembolization With Cispla...</td>\n",
       "      <td>DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...</td>\n",
       "      <td>OBJECTIVES:\n",
       "\n",
       "      Primary\n",
       "\n",
       "        -  ...</td>\n",
       "      <td>{'Hillman Cancer Center at University of Pitts...</td>\n",
       "      <td>All</td>\n",
       "      <td>120</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00109954</td>\n",
       "      <td>A Prospectively Randomized Controlled Clinical...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>RATIONALE: Drugs used in chemotherapy, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00128596</th>\n",
       "      <td>Arsenic Trioxide in Treating Patients With Met...</td>\n",
       "      <td>DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...</td>\n",
       "      <td>OBJECTIVES:\n",
       "\n",
       "        -  Determine the e...</td>\n",
       "      <td>{'UPMC Cancer Centers': {'city': 'Pittsburgh',...</td>\n",
       "      <td>All</td>\n",
       "      <td>120</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00128596</td>\n",
       "      <td>A Phase II Study of Trisenox (Arsenic Trioxide...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>RATIONALE: Drugs used in chemotherapy, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00132041</th>\n",
       "      <td>Radiofrequency Ablation in Treating Patients W...</td>\n",
       "      <td>DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...</td>\n",
       "      <td>OBJECTIVES:\n",
       "\n",
       "      Primary\n",
       "\n",
       "        -  ...</td>\n",
       "      <td>{'Lurleen Wallace Comprehensive Cancer at Univ...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00132041</td>\n",
       "      <td>Multicenter Feasibility Study of Percutaneous ...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>RATIONALE: Radiofrequency ablation uses...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00168987</th>\n",
       "      <td>Influence of an Oral Nutritional Supplement Ri...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  mal...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Charite University Hospital': {'city': 'Berl...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00168987</td>\n",
       "      <td>Pilot Study: Randomized Controlled Trial on th...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Malnutrition is a frequent symptom of v...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00183885</th>\n",
       "      <td>A Phase II Study of Intra-arterial Chemotherap...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Unr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'U.S.C. / Norris Comprehensive Cancer Center'...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00183885</td>\n",
       "      <td>A Phase II Study of Intra-arterial Chemotherap...</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This study is for people with cancer of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00247260</th>\n",
       "      <td>Safety of 32P BioSilicon in Patients With Hepa...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. Wri...</td>\n",
       "      <td>The study will enroll between 48 to 50 ...</td>\n",
       "      <td>{'Singapore General Hospital': {'city': 'Outra...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00247260</td>\n",
       "      <td>A Study of the Safety Profile of Three Escalat...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Brachytherapy is a recent technique use...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00282100</th>\n",
       "      <td>A Pilot Study of Adjuvant Therapy of Gefitinib...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "        Patholog...</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is one o...</td>\n",
       "      <td>{'Johns Hopkins Singapore International Center...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00282100</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This research is being done to find how...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00290316</th>\n",
       "      <td>Accuracy of Endoscopic Ultrasound for Detectio...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "        Patients...</td>\n",
       "      <td>The incidence of hepatocellular carcino...</td>\n",
       "      <td>{'Central Texas Veterans health Care System': ...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>0</td>\n",
       "      <td>NCT00290316</td>\n",
       "      <td>Accuracy of Endoscopic Ultrasound for Detectio...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The diagnostic accuracy of EUS for dete...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00386984</th>\n",
       "      <td>Hector-Study to Evaluate the Efficacy of Octre...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Ino...</td>\n",
       "      <td>A pilot study showed that octreotide ca...</td>\n",
       "      <td>{'University Medical Center Freiburg': {'city'...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00386984</td>\n",
       "      <td>Prospective, Randomized, Double-Blind, Placebo...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>A preliminary study has shown that the ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00410956</th>\n",
       "      <td>Floxuridine and Dexamethasone as a Hepatic Art...</td>\n",
       "      <td>DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...</td>\n",
       "      <td>OBJECTIVES:\n",
       "\n",
       "      Primary\n",
       "\n",
       "        -  ...</td>\n",
       "      <td>{'New York Weill Cornell Cancer Center at Corn...</td>\n",
       "      <td>All</td>\n",
       "      <td>120</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00410956</td>\n",
       "      <td>A Phase II Study of Hepatic Arterial Infusion ...</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>RATIONALE: Drugs used in chemotherapy, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00554125</th>\n",
       "      <td>Sirolimus-Based Immunosuppression Therapy in O...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  The...</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is one o...</td>\n",
       "      <td>{'Liver Cancer Institute and Zhongshan Hospita...</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00554125</td>\n",
       "      <td>A Prospective Randomised, Open-Labeled Study C...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of this study is to evaluat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00582400</th>\n",
       "      <td>A Phase II Protocol of Arsenic Trioxide (Trise...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Sig...</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is one o...</td>\n",
       "      <td>{'University of Texas Medical Branch at Galves...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00582400</td>\n",
       "      <td>A Phase II Protocol of Arsenic Trioxide (Trise...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of this study is: evaluate ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00589030</th>\n",
       "      <td>Yttrium Y 90 Radiolabeled Glass Beads in Treat...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Con...</td>\n",
       "      <td>OBJECTIVES:\n",
       "\n",
       "      Primary\n",
       "\n",
       "        -  ...</td>\n",
       "      <td>{'City of Hope Medical Center': {'city': 'Duar...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00589030</td>\n",
       "      <td>A Treatment of Unresectable Hepatocellular Car...</td>\n",
       "      <td>No longer available</td>\n",
       "      <td>Expanded Access</td>\n",
       "      <td>RATIONALE: Internal radiation therapy u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00739167</th>\n",
       "      <td>Quality of Life in Patients Undergoing Emboliz...</td>\n",
       "      <td>DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...</td>\n",
       "      <td>OBJECTIVES:\n",
       "\n",
       "      Primary\n",
       "\n",
       "        -  ...</td>\n",
       "      <td>{'Robert H. Lurie Comprehensive Cancer Center ...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00739167</td>\n",
       "      <td>A Quality of Life Study for Patients With Prim...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Observational</td>\n",
       "      <td>RATIONALE: Learning about quality of li...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00752063</th>\n",
       "      <td>Sorafenib With Capecitabine and Oxaliplatin fo...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Pat...</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is the m...</td>\n",
       "      <td>{'Queen Mary Hospital': {'city': 'Hong Kong', ...</td>\n",
       "      <td>All</td>\n",
       "      <td>80</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00752063</td>\n",
       "      <td>A Phase IIa Trial of Sorafenib With Capecitabi...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>HCC is an aggressive, largely chemo-res...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00759109</th>\n",
       "      <td>Pegylated Alfa-2b Interferon Therapy of Patien...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Cir...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{}</td>\n",
       "      <td>All</td>\n",
       "      <td>70</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00759109</td>\n",
       "      <td>Long-term Pegylated Alfa-2b Interferon Therapy...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This study aims to compare the role of ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00827554</th>\n",
       "      <td>The Role of Low Molecular Weight Heparins in H...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. Adu...</td>\n",
       "      <td>100 patients will be randomly assigned ...</td>\n",
       "      <td>{'Eastern Hepatobiliary Surgery Hospital': {'c...</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00827554</td>\n",
       "      <td>A Clinical Randomized Control Trial of Combina...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is a maj...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00844623</th>\n",
       "      <td>TK-based Suicide Gene Therapy for Hepatocellul...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Une...</td>\n",
       "      <td>The study is a phase I clinical trial e...</td>\n",
       "      <td>{'Clinica Universitaria de Navarra': {'city': ...</td>\n",
       "      <td>All</td>\n",
       "      <td>80</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00844623</td>\n",
       "      <td>Phase I Clinical Trial Of Gene Therapy For Hep...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of this study is to determi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00849264</th>\n",
       "      <td>Comprehensive Treatment for Different Types of...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Mal...</td>\n",
       "      <td>Primary liver cancer (PLC) has a great ...</td>\n",
       "      <td>{'Eastern hepatobilliary surgery hospital': {'...</td>\n",
       "      <td>All</td>\n",
       "      <td>60</td>\n",
       "      <td>30</td>\n",
       "      <td>NCT00849264</td>\n",
       "      <td>a Randomized Controlled Study of Surgical Comp...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This study is working to evaluate the s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00956436</th>\n",
       "      <td>Sorafenib With BIIB022 in Hepatocellular Carci...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Age...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Resesarch Site': {'city': 'Edgbaston', 'stat...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT00956436</td>\n",
       "      <td>A Phase 1b, Open-Label Study of Sorafenib With...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This is a phase 1b, open-Label study of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT01035229</th>\n",
       "      <td>Global Study Looking at the Combination of RAD...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Adv...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Highlands Oncology Group Dept of Highlands O...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT01035229</td>\n",
       "      <td>A Randomized Phase III, Double-blind, Placebo-...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of this study is to compare...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT01076517</th>\n",
       "      <td>A Humanitarian Device Exemption Treatment Prot...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "        Patients...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Stanford University School of Medicine': {'c...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>0</td>\n",
       "      <td>NCT01076517</td>\n",
       "      <td>A Humanitarian Device Exemption Treatment Prot...</td>\n",
       "      <td>Available</td>\n",
       "      <td>Expanded Access</td>\n",
       "      <td>To provide Therasphere treatment for pa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT01102335</th>\n",
       "      <td>Synergistic Treatment for Hepatocellular Carci...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  hep...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Liver cancer institute, Zhongshan Hospital, ...</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT01102335</td>\n",
       "      <td>The Observation Of Safety And Survival Of Hepa...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of this study is to elucida...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT01126645</th>\n",
       "      <td>Sorafenib and Micro-therapy Guided by Primovis...</td>\n",
       "      <td>Inclusion Criteria\n",
       "\n",
       "          1. Age:...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'University of Magdeburg': {'city': 'Magdebur...</td>\n",
       "      <td>All</td>\n",
       "      <td>85</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT01126645</td>\n",
       "      <td>Evaluation of Sorafenib in Combination With Lo...</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of this study is to evaluat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02528643</th>\n",
       "      <td>A Study to Assess the Efficacy and Safety of E...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Sub...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Site US10003': {'city': 'San Francisco', 'st...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02528643</td>\n",
       "      <td>A Phase 2, Randomized, Double-Blind, Placebo-C...</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of the study is to evaluate...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02534337</th>\n",
       "      <td>Gemcitabine Plus Oxaliplatin Versus Oxaliplati...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Eli...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{}</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02534337</td>\n",
       "      <td>Gemcitabine Plus Oxaliplatin (GEMOX) Versus Ox...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of this study is to determi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02537158</th>\n",
       "      <td>Sorafenib and TACE as Adjuvant Therapy for MVI...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  18-...</td>\n",
       "      <td>HCC is the sixth most common malignancy...</td>\n",
       "      <td>{'Cancer Hospital and Institute, Chinese Acade...</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02537158</td>\n",
       "      <td>Sorafenib and TACE as Adjuvant Therapy for MVI...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This study is a prospective non-randomi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02584556</th>\n",
       "      <td>Adjuvant Transcatheter Arterial Chemoembolizat...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. a p...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{}</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02584556</td>\n",
       "      <td>A Randomized Controlled Trial of Radical Hepat...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of this study is to determi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02599909</th>\n",
       "      <td>Gut Microbiota in People With Hepatocellular C...</td>\n",
       "      <td>-  INCLUSION CRITERIA:\n",
       "\n",
       "             ...</td>\n",
       "      <td>Background:\n",
       "\n",
       "      The human gut microb...</td>\n",
       "      <td>{'Icahn School of Medicine at Mount Sinai': {'...</td>\n",
       "      <td>All</td>\n",
       "      <td>99</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02599909</td>\n",
       "      <td>Gut Microbiota in Patients With HCC</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Background:\n",
       "\n",
       "      There are about 100 ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02616926</th>\n",
       "      <td>Hepatic Resection Versus TACE+RFA for BCLC Sta...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. Hep...</td>\n",
       "      <td>Barcelona Clinic Liver Cancer (BCLC) st...</td>\n",
       "      <td>{'Department of Hepatobiliary Surgery, Cancer ...</td>\n",
       "      <td>All</td>\n",
       "      <td>65</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02616926</td>\n",
       "      <td>Hepatic Resection Versus Transarterial Chemoem...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is the s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02646137</th>\n",
       "      <td>Single Session Combined Locoregional Therapies...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Chi...</td>\n",
       "      <td>To compare between combination treatmen...</td>\n",
       "      <td>{'Tanta university hospital': {'city': 'Tanta'...</td>\n",
       "      <td>All</td>\n",
       "      <td>70</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02646137</td>\n",
       "      <td>Comparison of Single Session Transarterial Che...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Hepatocellular carcinoma is the third m...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02670122</th>\n",
       "      <td>Prospective Study to Evaluate Safety of Deb-TA...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. Pat...</td>\n",
       "      <td>In this observational, prospective stud...</td>\n",
       "      <td>{'Fundación Jiménez Díaz': {'city': 'Madrid', ...</td>\n",
       "      <td>All</td>\n",
       "      <td>90</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02670122</td>\n",
       "      <td>Prospective, Multicenter, Non Randomized, Sing...</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Observational</td>\n",
       "      <td>This is an observational, multicenter, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02678806</th>\n",
       "      <td>Radiotherapy in Hepatocellular Carcinomas Afte...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. Pat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'TaoBai': {'city': 'Nanning', 'state': 'Guang...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>0</td>\n",
       "      <td>NCT02678806</td>\n",
       "      <td>Radiotherapy in Hepatocellular Carcinomas Afte...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Hepatocellular carcinoma is one of ten ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02702401</th>\n",
       "      <td>Study of Pembrolizumab (MK-3475) vs. Best Supp...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Has...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{}</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02702401</td>\n",
       "      <td>A Phase III Study of Pembrolizumab (MK-3475) v...</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This is a study of pembrolizumab (MK-34...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02743065</th>\n",
       "      <td>HepaSphere Chemoembolization in Advanced HCC P...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. Age...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Cancer Hospital Chinese Academy of Medical S...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02743065</td>\n",
       "      <td>Superselective Drug-Eluting Chemoembolization ...</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Observational</td>\n",
       "      <td>The purpose of this multicenter registr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02745600</th>\n",
       "      <td>Clinical Intervention Modelling, Planning and ...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  pri...</td>\n",
       "      <td>This ClinicIMPPACT proposal builds upon...</td>\n",
       "      <td>{'Medical University Graz': {'city': 'Graz', '...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02745600</td>\n",
       "      <td>Clinical Intervention Modelling, Planning and ...</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The main objective of the project is to...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02774187</th>\n",
       "      <td>Sorafenib Alone Versus Sorafenib Combined With...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  The...</td>\n",
       "      <td>The results of our preliminary pilot st...</td>\n",
       "      <td>{'Dongguan People 's Hospital': {'city': 'Dong...</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02774187</td>\n",
       "      <td>Sorafenib Alone Versus Sorafenib Combined With...</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of this study is to evaluat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02785380</th>\n",
       "      <td>Laparoscopic Surgery VS RFA for Recurrent HCC</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. Age...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{}</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02785380</td>\n",
       "      <td>Laparoscopic Surgery Versus Radiofrequency Abl...</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Management of recurrent HCC is urgent a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02961998</th>\n",
       "      <td>Preventive Effect of Celecoxib on Sorafenib-re...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  1.D...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{}</td>\n",
       "      <td>All</td>\n",
       "      <td>70</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02961998</td>\n",
       "      <td>Preventive Effect of Celecoxib on Sorafenib-re...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is a com...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT02967523</th>\n",
       "      <td>Surefire Precision Infusion System Registry</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Pat...</td>\n",
       "      <td>Conventional transarterial chemoemboliz...</td>\n",
       "      <td>{'UCLA': {'city': 'Los Angeles', 'state': 'Cal...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT02967523</td>\n",
       "      <td>Surefire Precision Infusion System Registry</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Observational [Patient Registry]</td>\n",
       "      <td>This project involves the collection an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03007225</th>\n",
       "      <td>Efficacy and Safety of Drug Eluting Beads TACE...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Con...</td>\n",
       "      <td>This prospective case control was condu...</td>\n",
       "      <td>{}</td>\n",
       "      <td>Male</td>\n",
       "      <td>65</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT03007225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This study aimed to to compare the conv...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03039322</th>\n",
       "      <td>Golgi Protein for HCC Diagnosis</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  pat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{}</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT03039322</td>\n",
       "      <td>Golgi Protein 73 for Diagnosis of HCC in Egypt...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Observational</td>\n",
       "      <td>This case-control study was conducted o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03047603</th>\n",
       "      <td>Evaluation of Diagnostic Efficiency of PIVKA-I...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Age...</td>\n",
       "      <td>Hepatocellular carcinoma (HCC) is the t...</td>\n",
       "      <td>{'Eastern hepatobiliary surgery hospital': {'c...</td>\n",
       "      <td>All</td>\n",
       "      <td>85</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT03047603</td>\n",
       "      <td>Evaluation of Diagnostic and Differential Diag...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Observational</td>\n",
       "      <td>The incidence of Hepatocellular carcino...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03145558</th>\n",
       "      <td>TATE Versus TACE in Intermediate Stage HCC</td>\n",
       "      <td>1. Confirmed diagnosis of HCC by imag...</td>\n",
       "      <td>Trans-arterial chemoembolization (TACE)...</td>\n",
       "      <td>{'University of California, Irvine': {'city': ...</td>\n",
       "      <td>All</td>\n",
       "      <td>85</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT03145558</td>\n",
       "      <td>TATE Versus TACE, an Open-label Randomized Stu...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>An open label randomized study to compa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03163992</th>\n",
       "      <td>Pembrolizumab in Advanced Hepatocellular Carci...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. Be ...</td>\n",
       "      <td>Each subject will participate in the tr...</td>\n",
       "      <td>{'Samsung Medical Center': {'city': 'Seoul', '...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>20</td>\n",
       "      <td>NCT03163992</td>\n",
       "      <td>Pembrolizumab in HCC</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This is a single-arm, single-center, op...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03208192</th>\n",
       "      <td>Comparison of Hydro-dissection Versus Ultrason...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Pat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{'Moscow Clinical scientific Center': {'city':...</td>\n",
       "      <td>All</td>\n",
       "      <td>80</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT03208192</td>\n",
       "      <td>Comparison of Hydro-dissection Versus Ultrason...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Background: until now, there is no agre...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03211416</th>\n",
       "      <td>Sorafenib Tosylate and Pembrolizumab in Treati...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Par...</td>\n",
       "      <td>PRIMARY OBJECTIVES:\n",
       "\n",
       "      I. To assess...</td>\n",
       "      <td>{'Roswell Park Cancer Institute': {'city': 'Bu...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT03211416</td>\n",
       "      <td>A Phase Ib/ II Study of Sorafenib and Pembroli...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This phase Ib/II trial studies how well...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03235167</th>\n",
       "      <td>Cytidine-phosphate-guanosine (CpG) DNA in Hepa...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  TNM...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{}</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>55</td>\n",
       "      <td>NCT03235167</td>\n",
       "      <td>Cytidine-phosphate-guanosine (CpG) DNA in Hepa...</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>to observe the outcome of hepatocellula...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03247296</th>\n",
       "      <td>Study of the Early Occurrence of Hepatocellula...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Pat...</td>\n",
       "      <td>Methodology:\n",
       "\n",
       "      Design:\n",
       "\n",
       "      Pros...</td>\n",
       "      <td>{'National Hepatology and Tropical Medicine Re...</td>\n",
       "      <td>All</td>\n",
       "      <td>75</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT03247296</td>\n",
       "      <td>Study of the Early Occurrence of Hepatocellula...</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Observational</td>\n",
       "      <td>To evaluate the early detection of HCC ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03268499</th>\n",
       "      <td>TACE Emulsion Versus Suspension</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. Wri...</td>\n",
       "      <td>Transcatheter arterial chemoembolizatio...</td>\n",
       "      <td>{'Department of Imaging and Interventional Rad...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT03268499</td>\n",
       "      <td>Lipiodol-based Transcatheter Arterial Chemoemb...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The aim of the study was to evaluate th...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03380130</th>\n",
       "      <td>A Study of the Safety and Antitumoral Efficacy...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Dia...</td>\n",
       "      <td>Worldwide, intra-arterial therapies are...</td>\n",
       "      <td>{'Hospital Universitario de Cruces': {'city': ...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT03380130</td>\n",
       "      <td>A Multicenter, Open-label, Single-arm Study of...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>The purpose of this study is to evaluat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03520257</th>\n",
       "      <td>The Study of Apatinib Plus Radiotherapy vs. Ap...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          1. Age...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>{}</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>18</td>\n",
       "      <td>NCT03520257</td>\n",
       "      <td>A Randomized Clinical Study of Apatinib Plus R...</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>This study uses to suppress the growth ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03594929</th>\n",
       "      <td>Effect of Remote Ischaemic preConditioning on ...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Pat...</td>\n",
       "      <td>Liver resection has improved health out...</td>\n",
       "      <td>{'Singapore General Hospital': {'city': 'Singa...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>21</td>\n",
       "      <td>NCT03594929</td>\n",
       "      <td>Effect of Remote Ischaemic preConditioning on ...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Liver resection has improved health out...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT03602703</th>\n",
       "      <td>Immune Responses in Hepatocellular Carcinoma P...</td>\n",
       "      <td>Inclusion Criteria:\n",
       "\n",
       "          -  Pat...</td>\n",
       "      <td>Clinical and laboratory assessment with...</td>\n",
       "      <td>{'Assiut University': {'city': 'Assiut', 'zip'...</td>\n",
       "      <td>All</td>\n",
       "      <td>100</td>\n",
       "      <td>0</td>\n",
       "      <td>NCT03602703</td>\n",
       "      <td>Detection of Immune Cell Responses in Chronic ...</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Case control Study to assess the differ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>100 rows × 12 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                   brief_title  \\\n",
       "NCT00004108    DX-8951f in Treating Patients With Liver Cancer   \n",
       "NCT00005997  Rebeccamycin Analogue in Treating Patients Wit...   \n",
       "NCT00006332  Treatment of Hepatocellular Carcinoma With Tet...   \n",
       "NCT00047346  Erlotinib in Treating Patients With Unresectab...   \n",
       "NCT00057395  A Safety and Effectiveness Study of Aroplatin ...   \n",
       "NCT00077441  Bortezomib in Treating Patients With Hepatocel...   \n",
       "NCT00109954  Hepatic Arterial Chemoembolization With Cispla...   \n",
       "NCT00128596  Arsenic Trioxide in Treating Patients With Met...   \n",
       "NCT00132041  Radiofrequency Ablation in Treating Patients W...   \n",
       "NCT00168987  Influence of an Oral Nutritional Supplement Ri...   \n",
       "NCT00183885  A Phase II Study of Intra-arterial Chemotherap...   \n",
       "NCT00247260  Safety of 32P BioSilicon in Patients With Hepa...   \n",
       "NCT00282100  A Pilot Study of Adjuvant Therapy of Gefitinib...   \n",
       "NCT00290316  Accuracy of Endoscopic Ultrasound for Detectio...   \n",
       "NCT00386984  Hector-Study to Evaluate the Efficacy of Octre...   \n",
       "NCT00410956  Floxuridine and Dexamethasone as a Hepatic Art...   \n",
       "NCT00554125  Sirolimus-Based Immunosuppression Therapy in O...   \n",
       "NCT00582400  A Phase II Protocol of Arsenic Trioxide (Trise...   \n",
       "NCT00589030  Yttrium Y 90 Radiolabeled Glass Beads in Treat...   \n",
       "NCT00739167  Quality of Life in Patients Undergoing Emboliz...   \n",
       "NCT00752063  Sorafenib With Capecitabine and Oxaliplatin fo...   \n",
       "NCT00759109  Pegylated Alfa-2b Interferon Therapy of Patien...   \n",
       "NCT00827554  The Role of Low Molecular Weight Heparins in H...   \n",
       "NCT00844623  TK-based Suicide Gene Therapy for Hepatocellul...   \n",
       "NCT00849264  Comprehensive Treatment for Different Types of...   \n",
       "NCT00956436  Sorafenib With BIIB022 in Hepatocellular Carci...   \n",
       "NCT01035229  Global Study Looking at the Combination of RAD...   \n",
       "NCT01076517  A Humanitarian Device Exemption Treatment Prot...   \n",
       "NCT01102335  Synergistic Treatment for Hepatocellular Carci...   \n",
       "NCT01126645  Sorafenib and Micro-therapy Guided by Primovis...   \n",
       "...                                                        ...   \n",
       "NCT02528643  A Study to Assess the Efficacy and Safety of E...   \n",
       "NCT02534337  Gemcitabine Plus Oxaliplatin Versus Oxaliplati...   \n",
       "NCT02537158  Sorafenib and TACE as Adjuvant Therapy for MVI...   \n",
       "NCT02584556  Adjuvant Transcatheter Arterial Chemoembolizat...   \n",
       "NCT02599909  Gut Microbiota in People With Hepatocellular C...   \n",
       "NCT02616926  Hepatic Resection Versus TACE+RFA for BCLC Sta...   \n",
       "NCT02646137  Single Session Combined Locoregional Therapies...   \n",
       "NCT02670122  Prospective Study to Evaluate Safety of Deb-TA...   \n",
       "NCT02678806  Radiotherapy in Hepatocellular Carcinomas Afte...   \n",
       "NCT02702401  Study of Pembrolizumab (MK-3475) vs. Best Supp...   \n",
       "NCT02743065  HepaSphere Chemoembolization in Advanced HCC P...   \n",
       "NCT02745600  Clinical Intervention Modelling, Planning and ...   \n",
       "NCT02774187  Sorafenib Alone Versus Sorafenib Combined With...   \n",
       "NCT02785380      Laparoscopic Surgery VS RFA for Recurrent HCC   \n",
       "NCT02961998  Preventive Effect of Celecoxib on Sorafenib-re...   \n",
       "NCT02967523        Surefire Precision Infusion System Registry   \n",
       "NCT03007225  Efficacy and Safety of Drug Eluting Beads TACE...   \n",
       "NCT03039322                    Golgi Protein for HCC Diagnosis   \n",
       "NCT03047603  Evaluation of Diagnostic Efficiency of PIVKA-I...   \n",
       "NCT03145558         TATE Versus TACE in Intermediate Stage HCC   \n",
       "NCT03163992  Pembrolizumab in Advanced Hepatocellular Carci...   \n",
       "NCT03208192  Comparison of Hydro-dissection Versus Ultrason...   \n",
       "NCT03211416  Sorafenib Tosylate and Pembrolizumab in Treati...   \n",
       "NCT03235167  Cytidine-phosphate-guanosine (CpG) DNA in Hepa...   \n",
       "NCT03247296  Study of the Early Occurrence of Hepatocellula...   \n",
       "NCT03268499                    TACE Emulsion Versus Suspension   \n",
       "NCT03380130  A Study of the Safety and Antitumoral Efficacy...   \n",
       "NCT03520257  The Study of Apatinib Plus Radiotherapy vs. Ap...   \n",
       "NCT03594929  Effect of Remote Ischaemic preConditioning on ...   \n",
       "NCT03602703  Immune Responses in Hepatocellular Carcinoma P...   \n",
       "\n",
       "                                                      criteria  \\\n",
       "NCT00004108  \n",
       "        DISEASE CHARACTERISTICS: Histological...   \n",
       "NCT00005997  \n",
       "        DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...   \n",
       "NCT00006332  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Pat...   \n",
       "NCT00047346  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  His...   \n",
       "NCT00057395  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Adv...   \n",
       "NCT00077441  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  His...   \n",
       "NCT00109954  \n",
       "        DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...   \n",
       "NCT00128596  \n",
       "        DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...   \n",
       "NCT00132041  \n",
       "        DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...   \n",
       "NCT00168987  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  mal...   \n",
       "NCT00183885  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Unr...   \n",
       "NCT00247260  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. Wri...   \n",
       "NCT00282100  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "        Patholog...   \n",
       "NCT00290316  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "        Patients...   \n",
       "NCT00386984  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Ino...   \n",
       "NCT00410956  \n",
       "        DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...   \n",
       "NCT00554125  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  The...   \n",
       "NCT00582400  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Sig...   \n",
       "NCT00589030  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Con...   \n",
       "NCT00739167  \n",
       "        DISEASE CHARACTERISTICS:\n",
       "\n",
       "          -...   \n",
       "NCT00752063  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Pat...   \n",
       "NCT00759109  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Cir...   \n",
       "NCT00827554  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. Adu...   \n",
       "NCT00844623  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Une...   \n",
       "NCT00849264  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Mal...   \n",
       "NCT00956436  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Age...   \n",
       "NCT01035229  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Adv...   \n",
       "NCT01076517  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "        Patients...   \n",
       "NCT01102335  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  hep...   \n",
       "NCT01126645  \n",
       "        Inclusion Criteria\n",
       "\n",
       "          1. Age:...   \n",
       "...                                                        ...   \n",
       "NCT02528643  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Sub...   \n",
       "NCT02534337  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Eli...   \n",
       "NCT02537158  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  18-...   \n",
       "NCT02584556  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. a p...   \n",
       "NCT02599909  \n",
       "        -  INCLUSION CRITERIA:\n",
       "\n",
       "             ...   \n",
       "NCT02616926  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. Hep...   \n",
       "NCT02646137  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Chi...   \n",
       "NCT02670122  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. Pat...   \n",
       "NCT02678806  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. Pat...   \n",
       "NCT02702401  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Has...   \n",
       "NCT02743065  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. Age...   \n",
       "NCT02745600  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  pri...   \n",
       "NCT02774187  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  The...   \n",
       "NCT02785380  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. Age...   \n",
       "NCT02961998  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  1.D...   \n",
       "NCT02967523  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Pat...   \n",
       "NCT03007225  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Con...   \n",
       "NCT03039322  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  pat...   \n",
       "NCT03047603  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Age...   \n",
       "NCT03145558  \n",
       "        1. Confirmed diagnosis of HCC by imag...   \n",
       "NCT03163992  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. Be ...   \n",
       "NCT03208192  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Pat...   \n",
       "NCT03211416  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Par...   \n",
       "NCT03235167  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  TNM...   \n",
       "NCT03247296  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Pat...   \n",
       "NCT03268499  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. Wri...   \n",
       "NCT03380130  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Dia...   \n",
       "NCT03520257  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          1. Age...   \n",
       "NCT03594929  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Pat...   \n",
       "NCT03602703  \n",
       "        Inclusion Criteria:\n",
       "\n",
       "          -  Pat...   \n",
       "\n",
       "                                                   description  \\\n",
       "NCT00004108  \n",
       "      OBJECTIVES: I. Evaluate the antitumor a...   \n",
       "NCT00005997  \n",
       "      OBJECTIVES:\n",
       "\n",
       "        -  Determine the r...   \n",
       "NCT00006332                                                NaN   \n",
       "NCT00047346  \n",
       "      PRIMARY OBJECTIVES:\n",
       "\n",
       "      I. Establish...   \n",
       "NCT00057395  \n",
       "      Primary Objective:\n",
       "\n",
       "        -  Determin...   \n",
       "NCT00077441  \n",
       "      PRIMARY OBJECTIVES:\n",
       "\n",
       "      I. Proportio...   \n",
       "NCT00109954  \n",
       "      OBJECTIVES:\n",
       "\n",
       "      Primary\n",
       "\n",
       "        -  ...   \n",
       "NCT00128596  \n",
       "      OBJECTIVES:\n",
       "\n",
       "        -  Determine the e...   \n",
       "NCT00132041  \n",
       "      OBJECTIVES:\n",
       "\n",
       "      Primary\n",
       "\n",
       "        -  ...   \n",
       "NCT00168987                                                NaN   \n",
       "NCT00183885                                                NaN   \n",
       "NCT00247260  \n",
       "      The study will enroll between 48 to 50 ...   \n",
       "NCT00282100  \n",
       "      Hepatocellular carcinoma (HCC) is one o...   \n",
       "NCT00290316  \n",
       "      The incidence of hepatocellular carcino...   \n",
       "NCT00386984  \n",
       "      A pilot study showed that octreotide ca...   \n",
       "NCT00410956  \n",
       "      OBJECTIVES:\n",
       "\n",
       "      Primary\n",
       "\n",
       "        -  ...   \n",
       "NCT00554125  \n",
       "      Hepatocellular carcinoma (HCC) is one o...   \n",
       "NCT00582400  \n",
       "      Hepatocellular carcinoma (HCC) is one o...   \n",
       "NCT00589030  \n",
       "      OBJECTIVES:\n",
       "\n",
       "      Primary\n",
       "\n",
       "        -  ...   \n",
       "NCT00739167  \n",
       "      OBJECTIVES:\n",
       "\n",
       "      Primary\n",
       "\n",
       "        -  ...   \n",
       "NCT00752063  \n",
       "      Hepatocellular carcinoma (HCC) is the m...   \n",
       "NCT00759109                                                NaN   \n",
       "NCT00827554  \n",
       "      100 patients will be randomly assigned ...   \n",
       "NCT00844623  \n",
       "      The study is a phase I clinical trial e...   \n",
       "NCT00849264  \n",
       "      Primary liver cancer (PLC) has a great ...   \n",
       "NCT00956436                                                NaN   \n",
       "NCT01035229                                                NaN   \n",
       "NCT01076517                                                NaN   \n",
       "NCT01102335                                                NaN   \n",
       "NCT01126645                                                NaN   \n",
       "...                                                        ...   \n",
       "NCT02528643                                                NaN   \n",
       "NCT02534337                                                NaN   \n",
       "NCT02537158  \n",
       "      HCC is the sixth most common malignancy...   \n",
       "NCT02584556                                                NaN   \n",
       "NCT02599909  \n",
       "      Background:\n",
       "\n",
       "      The human gut microb...   \n",
       "NCT02616926  \n",
       "      Barcelona Clinic Liver Cancer (BCLC) st...   \n",
       "NCT02646137  \n",
       "      To compare between combination treatmen...   \n",
       "NCT02670122  \n",
       "      In this observational, prospective stud...   \n",
       "NCT02678806                                                NaN   \n",
       "NCT02702401                                                NaN   \n",
       "NCT02743065                                                NaN   \n",
       "NCT02745600  \n",
       "      This ClinicIMPPACT proposal builds upon...   \n",
       "NCT02774187  \n",
       "      The results of our preliminary pilot st...   \n",
       "NCT02785380                                                NaN   \n",
       "NCT02961998                                                NaN   \n",
       "NCT02967523  \n",
       "      Conventional transarterial chemoemboliz...   \n",
       "NCT03007225  \n",
       "      This prospective case control was condu...   \n",
       "NCT03039322                                                NaN   \n",
       "NCT03047603  \n",
       "      Hepatocellular carcinoma (HCC) is the t...   \n",
       "NCT03145558  \n",
       "      Trans-arterial chemoembolization (TACE)...   \n",
       "NCT03163992  \n",
       "      Each subject will participate in the tr...   \n",
       "NCT03208192                                                NaN   \n",
       "NCT03211416  \n",
       "      PRIMARY OBJECTIVES:\n",
       "\n",
       "      I. To assess...   \n",
       "NCT03235167                                                NaN   \n",
       "NCT03247296  \n",
       "      Methodology:\n",
       "\n",
       "      Design:\n",
       "\n",
       "      Pros...   \n",
       "NCT03268499  \n",
       "      Transcatheter arterial chemoembolizatio...   \n",
       "NCT03380130  \n",
       "      Worldwide, intra-arterial therapies are...   \n",
       "NCT03520257                                                NaN   \n",
       "NCT03594929  \n",
       "      Liver resection has improved health out...   \n",
       "NCT03602703  \n",
       "      Clinical and laboratory assessment with...   \n",
       "\n",
       "                                                    facilities gender  \\\n",
       "NCT00004108  {'University of Colorado Cancer Center': {'cit...    All   \n",
       "NCT00005997  {'Comprehensive Cancer Center at University of...    All   \n",
       "NCT00006332  {'3912 Taubman Center': {'city': 'Ann Arbor', ...    All   \n",
       "NCT00047346  {'M D Anderson Cancer Center': {'city': 'Houst...    All   \n",
       "NCT00057395  {'John Wayne Cancer Institute': {'city': 'Sant...    All   \n",
       "NCT00077441  {'Mayo Clinic': {'city': 'Rochester', 'state':...    All   \n",
       "NCT00109954  {'Hillman Cancer Center at University of Pitts...    All   \n",
       "NCT00128596  {'UPMC Cancer Centers': {'city': 'Pittsburgh',...    All   \n",
       "NCT00132041  {'Lurleen Wallace Comprehensive Cancer at Univ...    All   \n",
       "NCT00168987  {'Charite University Hospital': {'city': 'Berl...    All   \n",
       "NCT00183885  {'U.S.C. / Norris Comprehensive Cancer Center'...    All   \n",
       "NCT00247260  {'Singapore General Hospital': {'city': 'Outra...    All   \n",
       "NCT00282100  {'Johns Hopkins Singapore International Center...    All   \n",
       "NCT00290316  {'Central Texas Veterans health Care System': ...    All   \n",
       "NCT00386984  {'University Medical Center Freiburg': {'city'...    All   \n",
       "NCT00410956  {'New York Weill Cornell Cancer Center at Corn...    All   \n",
       "NCT00554125  {'Liver Cancer Institute and Zhongshan Hospita...    All   \n",
       "NCT00582400  {'University of Texas Medical Branch at Galves...    All   \n",
       "NCT00589030  {'City of Hope Medical Center': {'city': 'Duar...    All   \n",
       "NCT00739167  {'Robert H. Lurie Comprehensive Cancer Center ...    All   \n",
       "NCT00752063  {'Queen Mary Hospital': {'city': 'Hong Kong', ...    All   \n",
       "NCT00759109                                                 {}    All   \n",
       "NCT00827554  {'Eastern Hepatobiliary Surgery Hospital': {'c...    All   \n",
       "NCT00844623  {'Clinica Universitaria de Navarra': {'city': ...    All   \n",
       "NCT00849264  {'Eastern hepatobilliary surgery hospital': {'...    All   \n",
       "NCT00956436  {'Resesarch Site': {'city': 'Edgbaston', 'stat...    All   \n",
       "NCT01035229  {'Highlands Oncology Group Dept of Highlands O...    All   \n",
       "NCT01076517  {'Stanford University School of Medicine': {'c...    All   \n",
       "NCT01102335  {'Liver cancer institute, Zhongshan Hospital, ...    All   \n",
       "NCT01126645  {'University of Magdeburg': {'city': 'Magdebur...    All   \n",
       "...                                                        ...    ...   \n",
       "NCT02528643  {'Site US10003': {'city': 'San Francisco', 'st...    All   \n",
       "NCT02534337                                                 {}    All   \n",
       "NCT02537158  {'Cancer Hospital and Institute, Chinese Acade...    All   \n",
       "NCT02584556                                                 {}    All   \n",
       "NCT02599909  {'Icahn School of Medicine at Mount Sinai': {'...    All   \n",
       "NCT02616926  {'Department of Hepatobiliary Surgery, Cancer ...    All   \n",
       "NCT02646137  {'Tanta university hospital': {'city': 'Tanta'...    All   \n",
       "NCT02670122  {'Fundación Jiménez Díaz': {'city': 'Madrid', ...    All   \n",
       "NCT02678806  {'TaoBai': {'city': 'Nanning', 'state': 'Guang...    All   \n",
       "NCT02702401                                                 {}    All   \n",
       "NCT02743065  {'Cancer Hospital Chinese Academy of Medical S...    All   \n",
       "NCT02745600  {'Medical University Graz': {'city': 'Graz', '...    All   \n",
       "NCT02774187  {'Dongguan People 's Hospital': {'city': 'Dong...    All   \n",
       "NCT02785380                                                 {}    All   \n",
       "NCT02961998                                                 {}    All   \n",
       "NCT02967523  {'UCLA': {'city': 'Los Angeles', 'state': 'Cal...    All   \n",
       "NCT03007225                                                 {}   Male   \n",
       "NCT03039322                                                 {}    All   \n",
       "NCT03047603  {'Eastern hepatobiliary surgery hospital': {'c...    All   \n",
       "NCT03145558  {'University of California, Irvine': {'city': ...    All   \n",
       "NCT03163992  {'Samsung Medical Center': {'city': 'Seoul', '...    All   \n",
       "NCT03208192  {'Moscow Clinical scientific Center': {'city':...    All   \n",
       "NCT03211416  {'Roswell Park Cancer Institute': {'city': 'Bu...    All   \n",
       "NCT03235167                                                 {}    All   \n",
       "NCT03247296  {'National Hepatology and Tropical Medicine Re...    All   \n",
       "NCT03268499  {'Department of Imaging and Interventional Rad...    All   \n",
       "NCT03380130  {'Hospital Universitario de Cruces': {'city': ...    All   \n",
       "NCT03520257                                                 {}    All   \n",
       "NCT03594929  {'Singapore General Hospital': {'city': 'Singa...    All   \n",
       "NCT03602703  {'Assiut University': {'city': 'Assiut', 'zip'...    All   \n",
       "\n",
       "             max_age  min_age       nct_id  \\\n",
       "NCT00004108      100       16  NCT00004108   \n",
       "NCT00005997      100       18  NCT00005997   \n",
       "NCT00006332      100       18  NCT00006332   \n",
       "NCT00047346      100       18  NCT00047346   \n",
       "NCT00057395      100       18  NCT00057395   \n",
       "NCT00077441      100       18  NCT00077441   \n",
       "NCT00109954      120       18  NCT00109954   \n",
       "NCT00128596      120       18  NCT00128596   \n",
       "NCT00132041      100       18  NCT00132041   \n",
       "NCT00168987      100       18  NCT00168987   \n",
       "NCT00183885      100       18  NCT00183885   \n",
       "NCT00247260      100       18  NCT00247260   \n",
       "NCT00282100      100       18  NCT00282100   \n",
       "NCT00290316      100        0  NCT00290316   \n",
       "NCT00386984      100       18  NCT00386984   \n",
       "NCT00410956      120       18  NCT00410956   \n",
       "NCT00554125       75       18  NCT00554125   \n",
       "NCT00582400      100       18  NCT00582400   \n",
       "NCT00589030      100       18  NCT00589030   \n",
       "NCT00739167      100       18  NCT00739167   \n",
       "NCT00752063       80       18  NCT00752063   \n",
       "NCT00759109       70       18  NCT00759109   \n",
       "NCT00827554       75       18  NCT00827554   \n",
       "NCT00844623       80       18  NCT00844623   \n",
       "NCT00849264       60       30  NCT00849264   \n",
       "NCT00956436      100       18  NCT00956436   \n",
       "NCT01035229      100       18  NCT01035229   \n",
       "NCT01076517      100        0  NCT01076517   \n",
       "NCT01102335       75       18  NCT01102335   \n",
       "NCT01126645       85       18  NCT01126645   \n",
       "...              ...      ...          ...   \n",
       "NCT02528643      100       18  NCT02528643   \n",
       "NCT02534337       75       18  NCT02534337   \n",
       "NCT02537158       75       18  NCT02537158   \n",
       "NCT02584556       75       18  NCT02584556   \n",
       "NCT02599909       99       18  NCT02599909   \n",
       "NCT02616926       65       18  NCT02616926   \n",
       "NCT02646137       70       18  NCT02646137   \n",
       "NCT02670122       90       18  NCT02670122   \n",
       "NCT02678806      100        0  NCT02678806   \n",
       "NCT02702401      100       18  NCT02702401   \n",
       "NCT02743065      100       18  NCT02743065   \n",
       "NCT02745600      100       18  NCT02745600   \n",
       "NCT02774187       75       18  NCT02774187   \n",
       "NCT02785380       75       18  NCT02785380   \n",
       "NCT02961998       70       18  NCT02961998   \n",
       "NCT02967523      100       18  NCT02967523   \n",
       "NCT03007225       65       18  NCT03007225   \n",
       "NCT03039322       75       18  NCT03039322   \n",
       "NCT03047603       85       18  NCT03047603   \n",
       "NCT03145558       85       18  NCT03145558   \n",
       "NCT03163992      100       20  NCT03163992   \n",
       "NCT03208192       80       18  NCT03208192   \n",
       "NCT03211416      100       18  NCT03211416   \n",
       "NCT03235167       75       55  NCT03235167   \n",
       "NCT03247296       75       18  NCT03247296   \n",
       "NCT03268499      100       18  NCT03268499   \n",
       "NCT03380130      100       18  NCT03380130   \n",
       "NCT03520257      100       18  NCT03520257   \n",
       "NCT03594929      100       21  NCT03594929   \n",
       "NCT03602703      100        0  NCT03602703   \n",
       "\n",
       "                                                official_title  \\\n",
       "NCT00004108  A Phase II Study of Intravenous DX-8951f Admin...   \n",
       "NCT00005997  Phase II and Pharmacokinetic Trial of Rebeccam...   \n",
       "NCT00006332                                                NaN   \n",
       "NCT00047346  A Dose-Finding, Safety, And Pharmacokinetic St...   \n",
       "NCT00057395  A Phase I/II Study of Aroplatin™ in Patients W...   \n",
       "NCT00077441  Phase II Trial of PS-341 in Patients With Hepa...   \n",
       "NCT00109954  A Prospectively Randomized Controlled Clinical...   \n",
       "NCT00128596  A Phase II Study of Trisenox (Arsenic Trioxide...   \n",
       "NCT00132041  Multicenter Feasibility Study of Percutaneous ...   \n",
       "NCT00168987  Pilot Study: Randomized Controlled Trial on th...   \n",
       "NCT00183885  A Phase II Study of Intra-arterial Chemotherap...   \n",
       "NCT00247260  A Study of the Safety Profile of Three Escalat...   \n",
       "NCT00282100                                                NaN   \n",
       "NCT00290316  Accuracy of Endoscopic Ultrasound for Detectio...   \n",
       "NCT00386984  Prospective, Randomized, Double-Blind, Placebo...   \n",
       "NCT00410956  A Phase II Study of Hepatic Arterial Infusion ...   \n",
       "NCT00554125  A Prospective Randomised, Open-Labeled Study C...   \n",
       "NCT00582400  A Phase II Protocol of Arsenic Trioxide (Trise...   \n",
       "NCT00589030  A Treatment of Unresectable Hepatocellular Car...   \n",
       "NCT00739167  A Quality of Life Study for Patients With Prim...   \n",
       "NCT00752063  A Phase IIa Trial of Sorafenib With Capecitabi...   \n",
       "NCT00759109  Long-term Pegylated Alfa-2b Interferon Therapy...   \n",
       "NCT00827554  A Clinical Randomized Control Trial of Combina...   \n",
       "NCT00844623  Phase I Clinical Trial Of Gene Therapy For Hep...   \n",
       "NCT00849264  a Randomized Controlled Study of Surgical Comp...   \n",
       "NCT00956436  A Phase 1b, Open-Label Study of Sorafenib With...   \n",
       "NCT01035229  A Randomized Phase III, Double-blind, Placebo-...   \n",
       "NCT01076517  A Humanitarian Device Exemption Treatment Prot...   \n",
       "NCT01102335  The Observation Of Safety And Survival Of Hepa...   \n",
       "NCT01126645  Evaluation of Sorafenib in Combination With Lo...   \n",
       "...                                                        ...   \n",
       "NCT02528643  A Phase 2, Randomized, Double-Blind, Placebo-C...   \n",
       "NCT02534337  Gemcitabine Plus Oxaliplatin (GEMOX) Versus Ox...   \n",
       "NCT02537158  Sorafenib and TACE as Adjuvant Therapy for MVI...   \n",
       "NCT02584556  A Randomized Controlled Trial of Radical Hepat...   \n",
       "NCT02599909                Gut Microbiota in Patients With HCC   \n",
       "NCT02616926  Hepatic Resection Versus Transarterial Chemoem...   \n",
       "NCT02646137  Comparison of Single Session Transarterial Che...   \n",
       "NCT02670122  Prospective, Multicenter, Non Randomized, Sing...   \n",
       "NCT02678806  Radiotherapy in Hepatocellular Carcinomas Afte...   \n",
       "NCT02702401  A Phase III Study of Pembrolizumab (MK-3475) v...   \n",
       "NCT02743065  Superselective Drug-Eluting Chemoembolization ...   \n",
       "NCT02745600  Clinical Intervention Modelling, Planning and ...   \n",
       "NCT02774187  Sorafenib Alone Versus Sorafenib Combined With...   \n",
       "NCT02785380  Laparoscopic Surgery Versus Radiofrequency Abl...   \n",
       "NCT02961998  Preventive Effect of Celecoxib on Sorafenib-re...   \n",
       "NCT02967523        Surefire Precision Infusion System Registry   \n",
       "NCT03007225                                                NaN   \n",
       "NCT03039322  Golgi Protein 73 for Diagnosis of HCC in Egypt...   \n",
       "NCT03047603  Evaluation of Diagnostic and Differential Diag...   \n",
       "NCT03145558  TATE Versus TACE, an Open-label Randomized Stu...   \n",
       "NCT03163992                               Pembrolizumab in HCC   \n",
       "NCT03208192  Comparison of Hydro-dissection Versus Ultrason...   \n",
       "NCT03211416  A Phase Ib/ II Study of Sorafenib and Pembroli...   \n",
       "NCT03235167  Cytidine-phosphate-guanosine (CpG) DNA in Hepa...   \n",
       "NCT03247296  Study of the Early Occurrence of Hepatocellula...   \n",
       "NCT03268499  Lipiodol-based Transcatheter Arterial Chemoemb...   \n",
       "NCT03380130  A Multicenter, Open-label, Single-arm Study of...   \n",
       "NCT03520257  A Randomized Clinical Study of Apatinib Plus R...   \n",
       "NCT03594929  Effect of Remote Ischaemic preConditioning on ...   \n",
       "NCT03602703  Detection of Immune Cell Responses in Chronic ...   \n",
       "\n",
       "                             status                        study_type  \\\n",
       "NCT00004108               Completed                    Interventional   \n",
       "NCT00005997              Terminated                    Interventional   \n",
       "NCT00006332               Completed                    Interventional   \n",
       "NCT00047346               Completed                    Interventional   \n",
       "NCT00057395          Unknown status                    Interventional   \n",
       "NCT00077441               Completed                    Interventional   \n",
       "NCT00109954               Completed                    Interventional   \n",
       "NCT00128596               Completed                    Interventional   \n",
       "NCT00132041          Unknown status                    Interventional   \n",
       "NCT00168987               Completed                    Interventional   \n",
       "NCT00183885  Active, not recruiting                    Interventional   \n",
       "NCT00247260          Unknown status                    Interventional   \n",
       "NCT00282100          Unknown status                    Interventional   \n",
       "NCT00290316          Unknown status                    Interventional   \n",
       "NCT00386984               Completed                    Interventional   \n",
       "NCT00410956  Active, not recruiting                    Interventional   \n",
       "NCT00554125          Unknown status                    Interventional   \n",
       "NCT00582400              Terminated                    Interventional   \n",
       "NCT00589030     No longer available                   Expanded Access   \n",
       "NCT00739167               Completed                     Observational   \n",
       "NCT00752063          Unknown status                    Interventional   \n",
       "NCT00759109               Completed                    Interventional   \n",
       "NCT00827554               Completed                    Interventional   \n",
       "NCT00844623               Completed                    Interventional   \n",
       "NCT00849264               Completed                    Interventional   \n",
       "NCT00956436               Completed                    Interventional   \n",
       "NCT01035229               Completed                    Interventional   \n",
       "NCT01076517               Available                   Expanded Access   \n",
       "NCT01102335          Unknown status                    Interventional   \n",
       "NCT01126645  Active, not recruiting                    Interventional   \n",
       "...                             ...                               ...   \n",
       "NCT02528643  Active, not recruiting                    Interventional   \n",
       "NCT02534337          Unknown status                    Interventional   \n",
       "NCT02537158          Unknown status                    Interventional   \n",
       "NCT02584556          Unknown status                    Interventional   \n",
       "NCT02599909      Not yet recruiting                     Observational   \n",
       "NCT02616926              Recruiting                    Interventional   \n",
       "NCT02646137              Recruiting                    Interventional   \n",
       "NCT02670122  Active, not recruiting                     Observational   \n",
       "NCT02678806              Recruiting                    Interventional   \n",
       "NCT02702401  Active, not recruiting                    Interventional   \n",
       "NCT02743065      Not yet recruiting                     Observational   \n",
       "NCT02745600          Unknown status                    Interventional   \n",
       "NCT02774187  Active, not recruiting                    Interventional   \n",
       "NCT02785380      Not yet recruiting                    Interventional   \n",
       "NCT02961998               Completed                    Interventional   \n",
       "NCT02967523              Recruiting  Observational [Patient Registry]   \n",
       "NCT03007225               Completed                    Interventional   \n",
       "NCT03039322               Completed                     Observational   \n",
       "NCT03047603              Recruiting                     Observational   \n",
       "NCT03145558              Recruiting                    Interventional   \n",
       "NCT03163992              Recruiting                    Interventional   \n",
       "NCT03208192              Recruiting                    Interventional   \n",
       "NCT03211416              Recruiting                    Interventional   \n",
       "NCT03235167      Not yet recruiting                    Interventional   \n",
       "NCT03247296  Active, not recruiting                     Observational   \n",
       "NCT03268499              Recruiting                    Interventional   \n",
       "NCT03380130              Recruiting                    Interventional   \n",
       "NCT03520257      Not yet recruiting                    Interventional   \n",
       "NCT03594929              Recruiting                    Interventional   \n",
       "NCT03602703      Not yet recruiting                     Observational   \n",
       "\n",
       "                                                       summary  \n",
       "NCT00004108  \n",
       "      RATIONALE: Drugs used in chemotherapy u...  \n",
       "NCT00005997  \n",
       "      RATIONALE: Drugs used in chemotherapy u...  \n",
       "NCT00006332  \n",
       "      Hepatocellular carcinoma (HCC) is a dea...  \n",
       "NCT00047346  \n",
       "      Phase I trial to study the effectivenes...  \n",
       "NCT00057395  \n",
       "      To determine the rate of response and t...  \n",
       "NCT00077441  \n",
       "      This phase II trial is studying how wel...  \n",
       "NCT00109954  \n",
       "      RATIONALE: Drugs used in chemotherapy, ...  \n",
       "NCT00128596  \n",
       "      RATIONALE: Drugs used in chemotherapy, ...  \n",
       "NCT00132041  \n",
       "      RATIONALE: Radiofrequency ablation uses...  \n",
       "NCT00168987  \n",
       "      Malnutrition is a frequent symptom of v...  \n",
       "NCT00183885  \n",
       "      This study is for people with cancer of...  \n",
       "NCT00247260  \n",
       "      Brachytherapy is a recent technique use...  \n",
       "NCT00282100  \n",
       "      This research is being done to find how...  \n",
       "NCT00290316  \n",
       "      The diagnostic accuracy of EUS for dete...  \n",
       "NCT00386984  \n",
       "      A preliminary study has shown that the ...  \n",
       "NCT00410956  \n",
       "      RATIONALE: Drugs used in chemotherapy, ...  \n",
       "NCT00554125  \n",
       "      The purpose of this study is to evaluat...  \n",
       "NCT00582400  \n",
       "      The purpose of this study is: evaluate ...  \n",
       "NCT00589030  \n",
       "      RATIONALE: Internal radiation therapy u...  \n",
       "NCT00739167  \n",
       "      RATIONALE: Learning about quality of li...  \n",
       "NCT00752063  \n",
       "      HCC is an aggressive, largely chemo-res...  \n",
       "NCT00759109  \n",
       "      This study aims to compare the role of ...  \n",
       "NCT00827554  \n",
       "      Hepatocellular carcinoma (HCC) is a maj...  \n",
       "NCT00844623  \n",
       "      The purpose of this study is to determi...  \n",
       "NCT00849264  \n",
       "      This study is working to evaluate the s...  \n",
       "NCT00956436  \n",
       "      This is a phase 1b, open-Label study of...  \n",
       "NCT01035229  \n",
       "      The purpose of this study is to compare...  \n",
       "NCT01076517  \n",
       "      To provide Therasphere treatment for pa...  \n",
       "NCT01102335  \n",
       "      The purpose of this study is to elucida...  \n",
       "NCT01126645  \n",
       "      The purpose of this study is to evaluat...  \n",
       "...                                                        ...  \n",
       "NCT02528643  \n",
       "      The purpose of the study is to evaluate...  \n",
       "NCT02534337  \n",
       "      The purpose of this study is to determi...  \n",
       "NCT02537158  \n",
       "      This study is a prospective non-randomi...  \n",
       "NCT02584556  \n",
       "      The purpose of this study is to determi...  \n",
       "NCT02599909  \n",
       "      Background:\n",
       "\n",
       "      There are about 100 ...  \n",
       "NCT02616926  \n",
       "      Hepatocellular carcinoma (HCC) is the s...  \n",
       "NCT02646137  \n",
       "      Hepatocellular carcinoma is the third m...  \n",
       "NCT02670122  \n",
       "      This is an observational, multicenter, ...  \n",
       "NCT02678806  \n",
       "      Hepatocellular carcinoma is one of ten ...  \n",
       "NCT02702401  \n",
       "      This is a study of pembrolizumab (MK-34...  \n",
       "NCT02743065  \n",
       "      The purpose of this multicenter registr...  \n",
       "NCT02745600  \n",
       "      The main objective of the project is to...  \n",
       "NCT02774187  \n",
       "      The purpose of this study is to evaluat...  \n",
       "NCT02785380  \n",
       "      Management of recurrent HCC is urgent a...  \n",
       "NCT02961998  \n",
       "      Hepatocellular carcinoma (HCC) is a com...  \n",
       "NCT02967523  \n",
       "      This project involves the collection an...  \n",
       "NCT03007225  \n",
       "      This study aimed to to compare the conv...  \n",
       "NCT03039322  \n",
       "      This case-control study was conducted o...  \n",
       "NCT03047603  \n",
       "      The incidence of Hepatocellular carcino...  \n",
       "NCT03145558  \n",
       "      An open label randomized study to compa...  \n",
       "NCT03163992  \n",
       "      This is a single-arm, single-center, op...  \n",
       "NCT03208192  \n",
       "      Background: until now, there is no agre...  \n",
       "NCT03211416  \n",
       "      This phase Ib/II trial studies how well...  \n",
       "NCT03235167  \n",
       "      to observe the outcome of hepatocellula...  \n",
       "NCT03247296  \n",
       "      To evaluate the early detection of HCC ...  \n",
       "NCT03268499  \n",
       "      The aim of the study was to evaluate th...  \n",
       "NCT03380130  \n",
       "      The purpose of this study is to evaluat...  \n",
       "NCT03520257  \n",
       "      This study uses to suppress the growth ...  \n",
       "NCT03594929  \n",
       "      Liver resection has improved health out...  \n",
       "NCT03602703  \n",
       "      Case control Study to assess the differ...  \n",
       "\n",
       "[100 rows x 12 columns]"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "trials_df[trials_df['max_age'] > 10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create column with all the text from brief_title, official_title, and summary\n",
    "trials_df['text'] = trials_df['brief_title'] + ' ' + \\\n",
    "                    trials_df['official_title'] + ' ' + \\\n",
    "                    trials_df['description'] + ' ' + \\\n",
    "                    trials_df['summary']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Function to format and tokenize data\n",
    "def trial_tokenizer(description):\n",
    "    description = str(description)\n",
    "    description = description.replace('\\n', '').replace('\\t', '')\n",
    "    for i in range(3):\n",
    "        description = description.replace('  ', ' ')\n",
    "    description = description.lower()\n",
    "    \n",
    "    return description"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [],
   "source": [
    "text = trials_df.text.apply(trial_tokenizer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT00004108    dx-8951f in treating patients with liver cance...\n",
       "NCT00005997    rebeccamycin analogue in treating patients wit...\n",
       "NCT00006332    treatment of hepatocellular carcinoma with tet...\n",
       "NCT00047346    erlotinib in treating patients with unresectab...\n",
       "NCT00057395    a safety and effectiveness study of aroplatin ...\n",
       "NCT00077441    bortezomib in treating patients with hepatocel...\n",
       "NCT00109954    hepatic arterial chemoembolization with cispla...\n",
       "NCT00128596    arsenic trioxide in treating patients with met...\n",
       "NCT00132041    radiofrequency ablation in treating patients w...\n",
       "NCT00168987    influence of an oral nutritional supplement ri...\n",
       "NCT00183885    a phase ii study of intra-arterial chemotherap...\n",
       "NCT00247260    safety of 32p biosilicon in patients with hepa...\n",
       "NCT00282100    a pilot study of adjuvant therapy of gefitinib...\n",
       "NCT00290316    accuracy of endoscopic ultrasound for detectio...\n",
       "NCT00322361    modified process hepatitis b vaccine in health...\n",
       "NCT00386984    hector-study to evaluate the efficacy of octre...\n",
       "NCT00410956    floxuridine and dexamethasone as a hepatic art...\n",
       "NCT00554125    sirolimus-based immunosuppression therapy in o...\n",
       "NCT00582400    a phase ii protocol of arsenic trioxide (trise...\n",
       "NCT00589030    yttrium y 90 radiolabeled glass beads in treat...\n",
       "NCT00739167    quality of life in patients undergoing emboliz...\n",
       "NCT00752063    sorafenib with capecitabine and oxaliplatin fo...\n",
       "NCT00759109    pegylated alfa-2b interferon therapy of patien...\n",
       "NCT00827554    the role of low molecular weight heparins in h...\n",
       "NCT00844623    tk-based suicide gene therapy for hepatocellul...\n",
       "NCT00849264    comprehensive treatment for different types of...\n",
       "NCT00956436    sorafenib with biib022 in hepatocellular carci...\n",
       "NCT01035229    global study looking at the combination of rad...\n",
       "NCT01076517    a humanitarian device exemption treatment prot...\n",
       "NCT01102335    synergistic treatment for hepatocellular carci...\n",
       "                                     ...                        \n",
       "NCT02528643    a study to assess the efficacy and safety of e...\n",
       "NCT02534337    gemcitabine plus oxaliplatin versus oxaliplati...\n",
       "NCT02537158    sorafenib and tace as adjuvant therapy for mvi...\n",
       "NCT02584556    adjuvant transcatheter arterial chemoembolizat...\n",
       "NCT02599909    gut microbiota in people with hepatocellular c...\n",
       "NCT02616926    hepatic resection versus tace+rfa for bclc sta...\n",
       "NCT02646137    single session combined locoregional therapies...\n",
       "NCT02670122    prospective study to evaluate safety of deb-ta...\n",
       "NCT02678806    radiotherapy in hepatocellular carcinomas afte...\n",
       "NCT02702401    study of pembrolizumab (mk-3475) vs. best supp...\n",
       "NCT02743065    hepasphere chemoembolization in advanced hcc p...\n",
       "NCT02745600    clinical intervention modelling, planning and ...\n",
       "NCT02774187    sorafenib alone versus sorafenib combined with...\n",
       "NCT02785380    laparoscopic surgery vs rfa for recurrent hcc ...\n",
       "NCT02961998    preventive effect of celecoxib on sorafenib-re...\n",
       "NCT02967523    surefire precision infusion system registry su...\n",
       "NCT03007225    efficacy and safety of drug eluting beads tace...\n",
       "NCT03039322    golgi protein for hcc diagnosis golgi protein ...\n",
       "NCT03047603    evaluation of diagnostic efficiency of pivka-i...\n",
       "NCT03145558    tate versus tace in intermediate stage hcc tat...\n",
       "NCT03163992    pembrolizumab in advanced hepatocellular carci...\n",
       "NCT03208192    comparison of hydro-dissection versus ultrason...\n",
       "NCT03211416    sorafenib tosylate and pembrolizumab in treati...\n",
       "NCT03235167    cytidine-phosphate-guanosine (cpg) dna in hepa...\n",
       "NCT03247296    study of the early occurrence of hepatocellula...\n",
       "NCT03268499    tace emulsion versus suspension lipiodol-based...\n",
       "NCT03380130    a study of the safety and antitumoral efficacy...\n",
       "NCT03520257    the study of apatinib plus radiotherapy vs. ap...\n",
       "NCT03594929    effect of remote ischaemic preconditioning on ...\n",
       "NCT03602703    immune responses in hepatocellular carcinoma p...\n",
       "Name: text, Length: 101, dtype: object"
      ]
     },
     "execution_count": 99,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## NLP, matrix decomposition and clustering analysis of clinical trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "metadata": {},
   "outputs": [],
   "source": [
    "from numpy.linalg import lstsq\n",
    "from numpy.linalg import norm\n",
    "import pandas as pd\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer\n",
    "from nltk import word_tokenize, sent_tokenize\n",
    "from sklearn.decomposition import NMF, TruncatedSVD"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {},
   "outputs": [],
   "source": [
    "tf = TfidfVectorizer(max_features=5000, stop_words='english')\n",
    "\n",
    "doc_term_mat = tf.fit_transform(text.values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "terms = np.array(tf.get_feature_names())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['000', '03', '04', ..., 'yttrium90', 'zd1839', 'μg'], \n",
       "      dtype='<U20')"
      ]
     },
     "execution_count": 107,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "terms"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "sklearn_nmf = NMF(max_iter=50, n_components=15)\n",
    "\n",
    "W = sklearn_nmf.fit_transform(doc_term_mat)\n",
    "H = sklearn_nmf.components_"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Topic 0 Most Common Words:\n",
      "----------------------------------\n",
      "rfa\n",
      "hcc\n",
      "ablation\n",
      "radiofrequency\n",
      "recurrent\n",
      "hepatectomy\n",
      "patients\n",
      "recurrence\n",
      "cirrhosis\n",
      "pht\n",
      "ls\n",
      "treatment\n",
      "outcomes\n",
      "rate\n",
      "considered\n",
      "hr\n",
      "prognosis\n",
      "assisted\n",
      "small\n",
      "systemic\n",
      "\n",
      "\n",
      "Topic 1 Most Common Words:\n",
      "----------------------------------\n",
      "oxaliplatin\n",
      "plus\n",
      "leucovorin\n",
      "fluorouracil\n",
      "gemcitabine\n",
      "folfox4\n",
      "advanced\n",
      "liposomal\n",
      "doxorubicin\n",
      "chemotherapy\n",
      "versus\n",
      "oxa\n",
      "ld\n",
      "gemox\n",
      "hcc\n",
      "haic\n",
      "gem\n",
      "prolonging\n",
      "pfs\n",
      "superior\n",
      "\n",
      "\n",
      "Topic 2 Most Common Words:\n",
      "----------------------------------\n",
      "patients\n",
      "arsenic\n",
      "trioxide\n",
      "tumor\n",
      "treating\n",
      "dx\n",
      "ii\n",
      "days\n",
      "ihc\n",
      "progression\n",
      "dose\n",
      "rebeccamycin\n",
      "8951f\n",
      "growth\n",
      "toxicity\n",
      "disease\n",
      "receive\n",
      "months\n",
      "cancer\n",
      "liver\n",
      "\n",
      "\n",
      "Topic 3 Most Common Words:\n",
      "----------------------------------\n",
      "tace\n",
      "chemoembolization\n",
      "transarterial\n",
      "intermediate\n",
      "patients\n",
      "beads\n",
      "hcc\n",
      "deb\n",
      "cyberknife\n",
      "embolization\n",
      "eluting\n",
      "stage\n",
      "tate\n",
      "carcinoma\n",
      "hepatocellular\n",
      "efficacy\n",
      "treatment\n",
      "100\n",
      "doxorubicin\n",
      "sbrt\n",
      "\n",
      "\n",
      "Topic 4 Most Common Words:\n",
      "----------------------------------\n",
      "therasphere\n",
      "treatment\n",
      "glass\n",
      "microspheres\n",
      "90\n",
      "yttrium\n",
      "patients\n",
      "cancer\n",
      "cisplatin\n",
      "life\n",
      "device\n",
      "quality\n",
      "liver\n",
      "blood\n",
      "exemption\n",
      "humanitarian\n",
      "tumor\n",
      "surgery\n",
      "unresectable\n",
      "embolization\n",
      "\n",
      "\n",
      "Topic 5 Most Common Words:\n",
      "----------------------------------\n",
      "margin\n",
      "narrow\n",
      "cm\n",
      "radiation\n",
      "therapy\n",
      "radiotherapy\n",
      "vein\n",
      "hepatectomy\n",
      "pvtt\n",
      "portal\n",
      "rt\n",
      "current\n",
      "microvascular\n",
      "carcinomas\n",
      "types\n",
      "thrombosis\n",
      "treatment\n",
      "recurrence\n",
      "resection\n",
      "invasion\n",
      "\n",
      "\n",
      "Topic 6 Most Common Words:\n",
      "----------------------------------\n",
      "subjects\n",
      "solid\n",
      "dose\n",
      "safety\n",
      "enzalutamide\n",
      "cohort\n",
      "advanced\n",
      "efficacy\n",
      "study\n",
      "phase\n",
      "122\n",
      "cc\n",
      "label\n",
      "open\n",
      "evaluate\n",
      "31121\n",
      "opb\n",
      "197\n",
      "arq\n",
      "carcinoma\n",
      "\n",
      "\n",
      "Topic 7 Most Common Words:\n",
      "----------------------------------\n",
      "bsc\n",
      "plus\n",
      "placebo\n",
      "supportive\n",
      "best\n",
      "care\n",
      "pembrolizumab\n",
      "inc280\n",
      "advanced\n",
      "rad001\n",
      "study\n",
      "sorafenib\n",
      "treatment\n",
      "3475\n",
      "mk\n",
      "patients\n",
      "hepatocellular\n",
      "carcinoma\n",
      "240\n",
      "systemically\n",
      "\n",
      "\n",
      "Topic 8 Most Common Words:\n",
      "----------------------------------\n",
      "hcc\n",
      "patients\n",
      "hcv\n",
      "serum\n",
      "group\n",
      "included\n",
      "pivka\n",
      "afp\n",
      "abdominal\n",
      "golgi\n",
      "diagnosis\n",
      "using\n",
      "protein\n",
      "triphasic\n",
      "45\n",
      "control\n",
      "liver\n",
      "ct\n",
      "egyptian\n",
      "diagnostic\n",
      "\n",
      "\n",
      "Topic 9 Most Common Words:\n",
      "----------------------------------\n",
      "laparoscopic\n",
      "resection\n",
      "liver\n",
      "left\n",
      "parenchyma\n",
      "comparison\n",
      "division\n",
      "ultrasonic\n",
      "hydro\n",
      "dissection\n",
      "aspirator\n",
      "transection\n",
      "hepatectomy\n",
      "center\n",
      "prospective\n",
      "randomized\n",
      "minimally\n",
      "invasive\n",
      "advantages\n",
      "versus\n",
      "\n",
      "\n",
      "Topic 10 Most Common Words:\n",
      "----------------------------------\n",
      "transcatheter\n",
      "chemoembolization\n",
      "arterial\n",
      "adjuvant\n",
      "anti\n",
      "microsphere\n",
      "kmg\n",
      "radical\n",
      "therapy\n",
      "hepatocellular\n",
      "virus\n",
      "tace\n",
      "advance\n",
      "systemic\n",
      "carinomas\n",
      "dna\n",
      "cpg\n",
      "hepatitis\n",
      "carcinoma\n",
      "chemotherapy\n",
      "\n",
      "\n",
      "Topic 11 Most Common Words:\n",
      "----------------------------------\n",
      "sorafenib\n",
      "advanced\n",
      "combined\n",
      "haic\n",
      "biib022\n",
      "hcc\n",
      "rna\n",
      "tumor\n",
      "tosylate\n",
      "growth\n",
      "hcv\n",
      "pembrolizumab\n",
      "1b\n",
      "study\n",
      "hepatocellular\n",
      "vessels\n",
      "carcinoma\n",
      "celecoxib\n",
      "syndrome\n",
      "foot\n",
      "\n",
      "\n",
      "Topic 12 Most Common Words:\n",
      "----------------------------------\n",
      "vaccine\n",
      "tm\n",
      "hepatitis\n",
      "recombinant\n",
      "tumor\n",
      "anti\n",
      "phase\n",
      "process\n",
      "hcc\n",
      "crcl\n",
      "intradermal\n",
      "allostim\n",
      "injections\n",
      "cancer\n",
      "personalized\n",
      "new\n",
      "designed\n",
      "infection\n",
      "cells\n",
      "involves\n",
      "\n",
      "\n",
      "Topic 13 Most Common Words:\n",
      "----------------------------------\n",
      "contrast\n",
      "mri\n",
      "imaging\n",
      "liver\n",
      "enhanced\n",
      "radiation\n",
      "cht\n",
      "surveillance\n",
      "patients\n",
      "adc\n",
      "group\n",
      "ultrasonography\n",
      "non\n",
      "breathing\n",
      "lesions\n",
      "ct\n",
      "ultrasound\n",
      "therapy\n",
      "local\n",
      "investigators\n",
      "\n",
      "\n",
      "Topic 14 Most Common Words:\n",
      "----------------------------------\n",
      "transplant\n",
      "olt\n",
      "sirolimus\n",
      "orthotopic\n",
      "milan\n",
      "criteria\n",
      "transplantation\n",
      "pretransplant\n",
      "patients\n",
      "liver\n",
      "bleeding\n",
      "prior\n",
      "hcc\n",
      "post\n",
      "recurrence\n",
      "likelihood\n",
      "24\n",
      "grade\n",
      "hcv\n",
      "patient\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for i, row in enumerate(H):\n",
    "    print(\"Topic\", i, \"Most Common Words:\")\n",
    "    print(\"----------------------------------\")\n",
    "    top = terms[np.argsort(row)[::-1][:20]]\n",
    "    for t in top:\n",
    "        print(t)\n",
    "    print(\"\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Topic 0 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC\n",
      "Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC\n",
      "Laparoscopic Surgery VS RFA for Recurrent HCC\n",
      "Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With Cirrhosis\n",
      "Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis\n",
      "HR Versus RFA for HCC in Patients With PHT\n",
      "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma\n",
      "Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma\n",
      "Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy\n",
      "HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer\n",
      "Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria\n",
      "Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration\n",
      "Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery\n",
      "\n",
      "\n",
      "Topic 1 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma\n",
      "Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma\n",
      "HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC\n",
      "RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma\n",
      "Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus\n",
      "Study of ARQ 197 in Hepatocellular Carcinoma (HCC)\n",
      "HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China\n",
      "A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies\n",
      "Surefire Precision Infusion System Registry\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma\n",
      "Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]\n",
      "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 2 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery\n",
      "DX-8951f in Treating Patients With Liver Cancer\n",
      "Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer\n",
      "Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)\n",
      "Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction\n",
      "Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery\n",
      "Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer\n",
      "A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver\n",
      "Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery\n",
      "Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC\n",
      "Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer\n",
      "Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies\n",
      "\n",
      "\n",
      "Topic 3 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "TATE Versus TACE in Intermediate Stage HCC\n",
      "Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC\n",
      "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma\n",
      "The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma\n",
      "Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients\n",
      "Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma\n",
      "Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma\n",
      "Surefire Precision Infusion System Registry\n",
      "TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma\n",
      "Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)\n",
      "TACE Emulsion Versus Suspension\n",
      "Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma\n",
      "Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy\n",
      "A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery\n",
      "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\n",
      "\n",
      "\n",
      "Topic 4 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery\n",
      "Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma (HCC)\n",
      "Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery\n",
      "A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma\n",
      "Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer\n",
      "A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma\n",
      "Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery\n",
      "Gut Microbiota in People With Hepatocellular Carcinoma (HCC)\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors\n",
      "TACE Emulsion Versus Suspension\n",
      "Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma\n",
      "Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma\n",
      "Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration\n",
      "The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer\n",
      "Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail\n",
      "\n",
      "\n",
      "Topic 5 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis\n",
      "Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion\n",
      "Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)\n",
      "Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients\n",
      "The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus\n",
      "A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma\n",
      "KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer\n",
      "Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\n",
      "TK-based Suicide Gene Therapy for Hepatocellular Carcinoma\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With Cirrhosis\n",
      "Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC\n",
      "Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail\n",
      "Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 6 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy\n",
      "Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma\n",
      "Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma\n",
      "A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma\n",
      "A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies\n",
      "Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)\n",
      "Study of ARQ 197 in Hepatocellular Carcinoma (HCC)\n",
      "TK-based Suicide Gene Therapy for Hepatocellular Carcinoma\n",
      "A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma\n",
      "HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China\n",
      "A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver\n",
      "A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma\n",
      "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\n",
      "Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib\n",
      "Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma\n",
      "TACE Emulsion Versus Suspension\n",
      "Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "\n",
      "\n",
      "Topic 7 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.\n",
      "Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240)\n",
      "Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma\n",
      "A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib\n",
      "Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib\n",
      "A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma\n",
      "Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma\n",
      "Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection\n",
      "Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC\n",
      "HR Versus RFA for HCC in Patients With PHT\n",
      "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma\n",
      "TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma\n",
      "Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 8 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Golgi Protein for HCC Diagnosis\n",
      "Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and Daclatasvir\n",
      "Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs\n",
      "Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC\n",
      "The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study\n",
      "Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver\n",
      "Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)\n",
      "Gut Microbiota in People With Hepatocellular Carcinoma (HCC)\n",
      "HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)\n",
      "HR Versus RFA for HCC in Patients With PHT\n",
      "HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma\n",
      "HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC\n",
      "Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant\n",
      "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 9 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Comparison of Hydro-dissection Versus Ultrasonic Aspirator in Division of Liver Parenchyma in Laparoscopic Resection\n",
      "Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection\n",
      "Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery\n",
      "Laparoscopic Surgery VS RFA for Recurrent HCC\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "Gut Microbiota in People With Hepatocellular Carcinoma (HCC)\n",
      "Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma\n",
      "Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With Cirrhosis\n",
      "Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma\n",
      "Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma\n",
      "Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma\n",
      "Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver\n",
      "Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail\n",
      "HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC\n",
      "Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction\n",
      "Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy\n",
      "HR Versus RFA for HCC in Patients With PHT\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC\n",
      "\n",
      "\n",
      "Topic 10 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma\n",
      "Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy\n",
      "Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas\n",
      "Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery\n",
      "Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma\n",
      "TACE Emulsion Versus Suspension\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "TK-based Suicide Gene Therapy for Hepatocellular Carcinoma\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma\n",
      "Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)\n",
      "Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer\n",
      "Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma\n",
      "RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 11 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)\n",
      "Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC\n",
      "Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail\n",
      "Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer\n",
      "Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)\n",
      "Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma\n",
      "Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion\n",
      "Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer\n",
      "Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma (HCC)\n",
      "Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)\n",
      "HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC\n",
      "A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib\n",
      "Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)\n",
      "Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer\n",
      "Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.\n",
      "Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma\n",
      "\n",
      "\n",
      "Topic 12 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "An Individualized Anti-Cancer Vaccine Study in Patients With HCC\n",
      "Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer\n",
      "A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection\n",
      "TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma\n",
      "Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy\n",
      "The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus\n",
      "Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration\n",
      "Gut Microbiota in People With Hepatocellular Carcinoma (HCC)\n",
      "A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC\n",
      "A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma\n",
      "HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)\n",
      "TK-based Suicide Gene Therapy for Hepatocellular Carcinoma\n",
      "Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma\n",
      "A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib\n",
      "Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery\n",
      "Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients\n",
      "\n",
      "\n",
      "Topic 13 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma\n",
      "Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]\n",
      "Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions\n",
      "Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy\n",
      "Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer\n",
      "KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer\n",
      "A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma\n",
      "Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver\n",
      "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases\n",
      "Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma\n",
      "Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study\n",
      "Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis\n",
      "Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib\n",
      "Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma\n",
      "Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors\n",
      "Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery\n",
      "\n",
      "\n",
      "Topic 14 Most Relevant Article Titles:\n",
      "----------------------------------\n",
      "Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)\n",
      "Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria\n",
      "Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant\n",
      "Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate\n",
      "Surefire Precision Infusion System Registry\n",
      "Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery\n",
      "Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection\n",
      "Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery\n",
      "LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma\n",
      "A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma\n",
      "Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma\n",
      "The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study\n",
      "Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)\n",
      "Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma\n",
      "A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC\n",
      "HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)\n",
      "HR Versus RFA for HCC in Patients With PHT\n",
      "Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma\n",
      "Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib\n",
      "Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "titles = trials_df['brief_title'].values\n",
    "\n",
    "for i in range(W.shape[1]):\n",
    "    topic_arr = W[:,i]\n",
    "    print(\"Topic\", i, \"Most Relevant Article Titles:\")\n",
    "    print(\"----------------------------------\")\n",
    "    top = titles[np.argsort(topic_arr)[::-1][:20]]\n",
    "    for t in top:\n",
    "        print(t)\n",
    "    print(\"\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "metadata": {},
   "outputs": [],
   "source": [
    "sklearn_svd = TruncatedSVD(n_components=15)\n",
    "test_s = sklearn_svd.fit_transform(doc_term_mat)\n",
    "test_d = sklearn_svd.components_"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Topic 0 Most Common Words:\n",
      "----------------------------------\n",
      "patients\n",
      "hcc\n",
      "sorafenib\n",
      "treatment\n",
      "study\n",
      "liver\n",
      "tumor\n",
      "hepatocellular\n",
      "carcinoma\n",
      "tace\n",
      "advanced\n",
      "chemoembolization\n",
      "cancer\n",
      "therapy\n",
      "rfa\n",
      "plus\n",
      "survival\n",
      "arterial\n",
      "safety\n",
      "phase\n",
      "\n",
      "\n",
      "Topic 1 Most Common Words:\n",
      "----------------------------------\n",
      "plus\n",
      "sorafenib\n",
      "oxaliplatin\n",
      "advanced\n",
      "bsc\n",
      "leucovorin\n",
      "fluorouracil\n",
      "gemcitabine\n",
      "folfox4\n",
      "supportive\n",
      "placebo\n",
      "best\n",
      "haic\n",
      "versus\n",
      "care\n",
      "liposomal\n",
      "hepatocellular\n",
      "carcinoma\n",
      "rad001\n",
      "pembrolizumab\n",
      "\n",
      "\n",
      "Topic 2 Most Common Words:\n",
      "----------------------------------\n",
      "hcc\n",
      "rfa\n",
      "tace\n",
      "hepatectomy\n",
      "resection\n",
      "recurrence\n",
      "recurrent\n",
      "ablation\n",
      "margin\n",
      "chemoembolization\n",
      "radiofrequency\n",
      "laparoscopic\n",
      "narrow\n",
      "prospective\n",
      "cm\n",
      "stage\n",
      "adjuvant\n",
      "intermediate\n",
      "transarterial\n",
      "versus\n",
      "\n",
      "\n",
      "Topic 3 Most Common Words:\n",
      "----------------------------------\n",
      "chemoembolization\n",
      "tace\n",
      "sorafenib\n",
      "arterial\n",
      "transcatheter\n",
      "transarterial\n",
      "combined\n",
      "intermediate\n",
      "hepatocellular\n",
      "anti\n",
      "hbv\n",
      "adjuvant\n",
      "kmg\n",
      "microsphere\n",
      "stage\n",
      "virus\n",
      "carcinoma\n",
      "combination\n",
      "therapy\n",
      "unresectable\n",
      "\n",
      "\n",
      "Topic 4 Most Common Words:\n",
      "----------------------------------\n",
      "sorafenib\n",
      "rfa\n",
      "hcv\n",
      "rna\n",
      "biib022\n",
      "olt\n",
      "transplant\n",
      "hcc\n",
      "ablation\n",
      "recurrence\n",
      "combined\n",
      "tosylate\n",
      "pembrolizumab\n",
      "group\n",
      "enhanced\n",
      "1b\n",
      "useful\n",
      "blood\n",
      "laparoscopic\n",
      "mri\n",
      "\n",
      "\n",
      "Topic 5 Most Common Words:\n",
      "----------------------------------\n",
      "margin\n",
      "narrow\n",
      "radiation\n",
      "cm\n",
      "radiotherapy\n",
      "vein\n",
      "therasphere\n",
      "portal\n",
      "therapy\n",
      "pvtt\n",
      "hepatectomy\n",
      "rt\n",
      "treatment\n",
      "tumor\n",
      "microvascular\n",
      "types\n",
      "current\n",
      "carcinomas\n",
      "thrombosis\n",
      "adjuvant\n",
      "\n",
      "\n",
      "Topic 6 Most Common Words:\n",
      "----------------------------------\n",
      "subjects\n",
      "dose\n",
      "solid\n",
      "phase\n",
      "safety\n",
      "cohort\n",
      "enzalutamide\n",
      "vaccine\n",
      "efficacy\n",
      "aroplatin\n",
      "malignancies\n",
      "evaluate\n",
      "122\n",
      "cc\n",
      "hepatitis\n",
      "open\n",
      "label\n",
      "hcc\n",
      "advanced\n",
      "margin\n",
      "\n",
      "\n",
      "Topic 7 Most Common Words:\n",
      "----------------------------------\n",
      "bsc\n",
      "placebo\n",
      "supportive\n",
      "best\n",
      "efficacy\n",
      "care\n",
      "pembrolizumab\n",
      "cyberknife\n",
      "radiation\n",
      "inc280\n",
      "imaging\n",
      "treatment\n",
      "rad001\n",
      "plus\n",
      "enzalutamide\n",
      "laparoscopic\n",
      "study\n",
      "vs\n",
      "safety\n",
      "subjects\n",
      "\n",
      "\n",
      "Topic 8 Most Common Words:\n",
      "----------------------------------\n",
      "hepatitis\n",
      "vaccine\n",
      "hcv\n",
      "plus\n",
      "virus\n",
      "ultrasonography\n",
      "radiation\n",
      "anti\n",
      "oxaliplatin\n",
      "serum\n",
      "eus\n",
      "recombinant\n",
      "group\n",
      "blood\n",
      "surveillance\n",
      "imaging\n",
      "therapy\n",
      "using\n",
      "transplant\n",
      "tm\n",
      "\n",
      "\n",
      "Topic 9 Most Common Words:\n",
      "----------------------------------\n",
      "laparoscopic\n",
      "resection\n",
      "liver\n",
      "surgery\n",
      "cisplatin\n",
      "therasphere\n",
      "left\n",
      "transcatheter\n",
      "blood\n",
      "randomized\n",
      "arterial\n",
      "parenchyma\n",
      "adjuvant\n",
      "controlled\n",
      "study\n",
      "life\n",
      "quality\n",
      "center\n",
      "88\n",
      "subjects\n",
      "\n",
      "\n",
      "Topic 10 Most Common Words:\n",
      "----------------------------------\n",
      "subjects\n",
      "cisplatin\n",
      "therasphere\n",
      "mitomycin\n",
      "sorafenib\n",
      "biib022\n",
      "oxaliplatin\n",
      "contrast\n",
      "fluorouracil\n",
      "mri\n",
      "enzalutamide\n",
      "radiation\n",
      "122\n",
      "cc\n",
      "label\n",
      "leucovorin\n",
      "open\n",
      "imaging\n",
      "drug\n",
      "blood\n",
      "\n",
      "\n",
      "Topic 11 Most Common Words:\n",
      "----------------------------------\n",
      "portal\n",
      "vein\n",
      "rt\n",
      "dose\n",
      "tumor\n",
      "apatinib\n",
      "pvtt\n",
      "radiation\n",
      "thrombus\n",
      "haic\n",
      "thrombi\n",
      "advanced\n",
      "hcc\n",
      "patients\n",
      "efficacy\n",
      "infusion\n",
      "safety\n",
      "registry\n",
      "comprehensive\n",
      "hepasphere\n",
      "\n",
      "\n",
      "Topic 12 Most Common Words:\n",
      "----------------------------------\n",
      "vaccine\n",
      "rfa\n",
      "recombinant\n",
      "subjects\n",
      "tm\n",
      "ablation\n",
      "pembrolizumab\n",
      "treatment\n",
      "hepatitis\n",
      "tumor\n",
      "anti\n",
      "process\n",
      "adenovirus\n",
      "tumors\n",
      "radiofrequency\n",
      "apatinib\n",
      "phase\n",
      "human\n",
      "bsc\n",
      "vein\n",
      "\n",
      "\n",
      "Topic 13 Most Common Words:\n",
      "----------------------------------\n",
      "life\n",
      "quality\n",
      "group\n",
      "adjuvant\n",
      "ablation\n",
      "transcatheter\n",
      "rfa\n",
      "patients\n",
      "octreotide\n",
      "local\n",
      "32p\n",
      "patient\n",
      "nutritional\n",
      "epa\n",
      "supplement\n",
      "dose\n",
      "surveys\n",
      "tumour\n",
      "sorafenib\n",
      "arterial\n",
      "\n",
      "\n",
      "Topic 14 Most Common Words:\n",
      "----------------------------------\n",
      "therasphere\n",
      "unresectable\n",
      "cyberknife\n",
      "dose\n",
      "protocol\n",
      "humanitarian\n",
      "exemption\n",
      "radiation\n",
      "device\n",
      "recombinant\n",
      "transarterial\n",
      "adenovirus\n",
      "transplant\n",
      "vaccine\n",
      "recurrent\n",
      "carcinoma\n",
      "treatment\n",
      "sorafenib\n",
      "injection\n",
      "type\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for i, row in enumerate(test_d):\n",
    "    print(\"Topic\", i, \"Most Common Words:\")\n",
    "    print(\"----------------------------------\")\n",
    "    top = terms[np.argsort(row)[::-1][:20]]\n",
    "    for t in top:\n",
    "        print(t)\n",
    "    print(\"\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
